rfhg_191343.1

Basic information about the TSS

---

TSS ID: rfhg_191343.1 Species: human Chr: chr17		Start: 28717743 End: 28717765 Strand: -
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D2919931,EH38E1854166)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000395243.7:0 BC016841:0 GeneID: 83871 HGNC/MGI_ID: HGNC:16519 UniProt_ID: A0A1C7CYW6 Nearer transcript ids and distances: LF326828:20 MA562405:20 LF213771:-29 MA449348:-29 ENST00000636513.1:35 ENST00000636154.2:35 ENST00000483554.1:36 ENST00000636772.1:-85 ENST00000395245.9:-103 NM_001256281.3:-103 NM_031934.6:-103 NM_001144942.2:-103 AK074689:-103 BC091510:317 ENST00000422279.6:350 LF326829:387 MA562406:387 AF327350:-390 ENST00000436730.7:-396 ENST00000625712.2:-401 ENST00000450529.5:-401 AK297850:-401 ENST00000583538.5:-402 ENST00000419712.7:-402 ENST00000580843.6:-402 ENST00000482688.5:-402 ENST00000582934.1:-402 NM_001256277.2:-402 NM_001256276.2:-402 AK027312:-402 AJ277106:-404 ENST00000415040.6:-418 BC066904:-418 AK304633:-418 ENST00000353676.9:-457 AF322067:477 CU677737:477 KJ894907:477 KJ899729:477 BT006702:477 DQ890590:477 DQ893756:477 CU688184:477 view more...

Gene_name: RAB34, member RAS oncogene family Gene_symbol: RAB34 Gene_synonyms: NARR RAB39 RAH Gene_source: HGNC:16519

TATA-Box annotation

---

Distance to TSS:	114
Nearest PromoterID:	NM_031934
Entrez ID:	83871
Nearest Unigene:	Hs.301853
Nearest Refseq:	NM_031934
Nearest Ensembl:	ENSG00000109113
Gene Name:	RAB34, member RAS oncogene family
Gene Alias:	NARR|RAB39|RAH
Gene Type:	protein-coding
CpG%:	0.045455
GC%:	0.695652
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@RAB34 p2@RAB34 p3@RAB34 p4@RAB34 p5@RAB34 p6@RAB34 p7@RAB34 p8@RAB34
Sample		p1@RAB34	p2@RAB34	p3@RAB34	p4@RAB34	p5@RAB34	p6@RAB34	p7@RAB34	p8@RAB34
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	26.49	19.29	9.93	4.87	3.12	2.92	0.39	1.56
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	30.55	22.26	11.94	6.07	5.66	4.86	0.40	1.21
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	25.27	20.06	9.65	4.82	5.21	3.28	0.19	0.96
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	29.52	12.68	8.73	5.20	2.70	3.74	0.00	1.25
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	29.25	13.95	7.87	6.07	4.27	2.92	0.00	0.90
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	25.97	14.92	5.81	5.81	2.13	3.29	0.19	0.19
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	63.84	25.93	8.06	7.84	3.27	5.01	0.44	1.53
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	53.29	21.56	10.17	4.60	5.09	3.88	0.24	2.42
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	55.14	25.65	9.83	5.56	5.34	5.13	0.43	1.71
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	70.13	23.19	9.27	4.64	4.06	2.90	0.58	2.32
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	88.93	19.81	13.74	3.23	2.43	4.45	0.00	2.02
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	78.87	14.23	10.98	2.44	2.03	2.44	0.41	2.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	64.32	20.31	21.44	2.42	4.51	1.13	0.00	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	64.95	14.73	16.54	2.71	3.91	0.90	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	63.01	16.69	18.66	2.42	2.63	1.32	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	64.63	19.11	18.11	2.77	3.52	1.01	0.00	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	63.12	19.00	14.85	1.75	2.62	2.18	0.00	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	67.91	18.14	16.87	1.69	1.69	0.84	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	75.17	14.93	21.33	3.73	3.20	1.07	1.07	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	68.00	24.22	24.37	4.66	3.76	2.26	0.00	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	72.97	22.19	23.12	4.14	3.88	1.87	0.13	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	72.50	29.69	17.61	6.39	4.66	3.11	0.00	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	67.86	22.62	15.38	4.52	4.14	1.94	0.13	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	66.73	29.61	19.66	5.82	5.58	3.40	0.00	1.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	74.30	28.89	20.64	11.35	6.45	1.29	0.26	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	81.34	33.87	17.41	10.44	6.96	6.01	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	71.98	27.47	14.29	12.09	7.14	3.30	0.00	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	75.44	35.36	25.23	14.85	5.42	5.42	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	67.36	31.34	22.29	12.11	7.75	3.88	0.16	1.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	72.21	30.40	19.18	12.67	8.69	6.33	0.18	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	87.51	32.66	17.17	12.56	8.58	4.81	0.21	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	80.69	33.41	17.78	12.90	9.38	5.08	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	77.66	29.97	12.66	10.97	5.49	3.59	0.00	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	70.92	23.42	15.17	13.36	5.11	6.76	0.00	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	80.03	36.09	19.07	12.90	7.29	3.74	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	73.77	33.92	22.04	14.56	5.37	5.75	0.38	2.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	77.05	31.68	23.91	14.92	6.34	6.34	0.20	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	78.18	34.66	17.13	12.29	6.85	3.83	0.00	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	81.03	34.03	15.67	12.69	5.13	5.13	0.00	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	72.26	29.29	18.24	14.16	6.00	5.04	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	74.34	38.11	17.64	10.12	8.70	5.88	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	73.49	26.94	16.10	10.10	4.25	7.17	0.00	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	77.61	38.80	20.03	8.44	8.01	4.64	0.00	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	80.07	35.14	20.63	12.59	8.22	6.99	0.35	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	75.69	37.14	21.08	14.05	9.03	5.42	0.00	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	76.08	40.71	18.38	8.61	7.68	6.51	0.23	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	73.17	37.19	22.31	10.08	8.40	5.76	0.00	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	85.24	36.36	22.95	12.22	8.94	6.56	0.00	0.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	82.11	45.96	22.98	12.21	7.42	4.07	0.24	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	81.89	35.38	19.82	11.32	6.67	5.46	0.00	1.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	63.95	31.77	14.55	9.02	4.51	4.92	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	95.18	34.25	14.45	11.79	7.78	7.78	0.00	1.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	83.95	0.00	13.99	27.98	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	77.71	26.97	12.07	7.45	6.39	5.32	0.35	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	69.26	26.51	11.93	3.31	7.29	5.30	0.00	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	18.46	14.26	12.58	4.19	4.19	2.52	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	43.63	16.07	14.24	3.67	3.21	5.51	0.00	0.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	62.88	29.49	12.64	6.81	8.75	3.89	0.00	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	66.16	26.98	10.60	3.21	7.71	5.46	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	38.35	21.06	16.66	2.83	6.92	6.60	0.00	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	53.58	18.33	11.28	1.41	2.12	4.23	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	56.08	19.63	9.53	3.36	4.49	2.24	0.00	1.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	15.92	24.68	16.72	4.78	1.59	1.59	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	56.40	21.41	13.25	2.38	4.08	5.44	0.00	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	73.11	27.29	13.97	4.22	5.85	4.22	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	79.87	19.88	13.13	2.48	4.97	4.61	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	16.16	0.00	0.00	0.00	0.00	16.16	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	23.69	7.90	15.79	0.00	7.90	7.90	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	58.01	26.33	9.26	2.44	3.90	1.95	0.00	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	49.09	19.34	8.93	2.48	1.98	1.49	0.00	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	56.76	16.89	11.26	2.81	4.22	2.81	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	49.68	26.83	16.23	2.98	3.64	0.99	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	54.13	25.37	12.99	0.62	5.26	2.47	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	61.45	24.46	10.09	2.75	7.34	2.45	0.00	0.61
Adipocyte - breast, donor1	11376-118A8	31.20	22.33	9.50	0.63	0.95	2.22	0.00	0.63
Adipocyte - breast, donor2	11327-117E4	15.24	17.97	9.14	0.16	1.12	0.80	0.32	0.32
Adipocyte - omental, donor1	11473-119C6	23.16	16.03	8.27	0.38	0.51	1.91	0.76	0.25
Adipocyte - omental, donor2	11474-119C7	28.40	22.42	15.70	2.99	2.24	2.24	0.00	0.75
Adipocyte - omental, donor3	11475-119C8	25.45	15.07	10.05	0.67	3.01	2.68	0.33	0.33
Adipocyte - perirenal, donor1	11476-119C9	29.35	34.45	12.12	0.00	1.91	1.28	0.00	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	18.69	7.70	6.60	1.10	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	57.36	17.61	6.32	0.90	1.81	0.90	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	33.54	5.39	6.78	0.70	0.17	0.52	0.00	0.35
Adipocyte differentiation, day04, donor1	13019-139D4	41.66	6.85	9.58	0.39	0.59	1.17	0.20	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	43.75	7.21	8.75	0.26	0.26	2.06	0.51	0.77
Adipocyte differentiation, day04, donor3	13025-139E1	48.79	8.08	9.20	0.84	0.00	0.56	0.00	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	51.14	7.05	9.40	0.00	1.18	0.00	1.18	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	10.86	2.25	3.78	0.40	0.48	0.48	0.00	0.00
Adipocyte differentiation, day08, donor2	13023-139D8	29.37	5.49	7.75	0.00	0.65	0.32	0.00	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	17.60	4.27	8.53	1.60	1.07	0.53	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	22.26	2.78	7.23	0.00	1.11	0.56	0.00	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	12.89	4.57	3.74	1.66	1.25	1.25	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	19.09	4.52	4.52	0.50	0.50	1.00	0.00	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	12.76	2.95	4.58	0.33	0.65	1.64	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	4.26	1.22	2.74	0.00	0.00	0.61	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	81.55	23.87	8.62	4.42	2.87	3.54	0.66	1.10
Alveolar Epithelial Cells, donor2	11590-120G6	147.38	38.01	27.25	7.89	4.66	7.53	0.36	1.43
Alveolar Epithelial Cells, donor3	11671-122G6	51.51	19.17	9.58	4.79	3.59	2.40	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	66.74	11.69	9.53	0.90	1.98	1.44	0.18	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	76.98	15.06	18.41	1.67	3.35	1.67	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	62.46	19.93	16.23	1.44	3.49	1.44	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	134.22	22.08	9.27	3.43	4.00	2.29	1.03	0.69
Anulus Pulposus Cell, donor2	11463-119B5	102.37	22.29	15.43	2.94	3.43	1.71	0.00	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	43.58	16.62	9.44	1.80	1.35	4.04	0.90	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	56.00	17.37	6.08	0.43	2.17	4.34	2.17	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	62.07	17.12	10.70	0.00	0.00	2.14	2.14	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	44.84	16.44	9.27	2.99	1.49	1.20	1.20	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	64.50	13.91	15.18	1.26	2.53	6.32	0.00	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	56.77	12.54	6.60	0.66	0.00	1.98	3.96	1.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	37.69	15.59	7.47	0.65	0.97	0.97	0.65	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	46.60	17.96	8.25	2.91	2.43	3.88	1.94	1.94
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	74.23	17.22	5.34	3.56	2.97	1.19	1.19	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	41.05	13.94	6.03	1.51	1.88	1.88	1.51	0.75
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	37.74	15.24	8.71	3.63	2.90	4.35	2.18	2.18
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	66.45	17.55	3.76	0.00	1.25	2.51	1.25	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	63.75	23.06	5.77	1.15	2.80	2.14	1.48	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	46.40	10.92	5.46	1.36	0.00	2.73	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	62.58	14.93	6.03	0.75	0.90	3.02	1.06	1.81
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	48.22	17.15	6.43	1.61	1.61	2.68	1.07	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	51.01	18.52	10.77	0.94	2.46	2.46	2.46	0.38
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	60.67	19.24	6.95	2.67	1.87	2.41	1.60	0.53
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	50.72	20.48	3.90	4.88	1.95	0.98	0.98	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	44.12	22.56	8.29	1.82	1.99	2.32	1.16	0.17
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	48.03	27.62	4.80	0.00	2.40	1.20	3.60	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	38.94	28.32	3.54	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	43.05	16.81	6.18	1.89	1.37	2.06	0.86	0.69
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	83.90	12.58	4.19	0.00	4.19	0.00	12.58	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	46.12	15.05	4.37	1.46	2.91	2.91	0.97	1.46
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	50.47	22.77	9.87	3.42	2.66	2.66	1.52	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	65.41	18.17	12.11	1.21	2.42	3.63	1.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	50.73	17.10	13.11	1.71	3.42	2.85	2.28	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	56.86	16.03	8.34	0.86	1.50	1.71	1.50	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	63.75	16.78	5.94	2.84	2.06	1.29	0.77	0.52
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	44.57	15.95	6.57	1.41	0.94	4.22	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	43.73	15.76	8.36	0.32	1.93	1.61	0.96	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	57.08	16.41	5.71	0.71	0.00	2.14	1.43	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	46.80	16.38	10.53	2.92	2.92	1.17	1.17	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	46.06	15.96	8.13	1.51	0.30	0.90	1.20	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	59.40	20.20	9.50	0.00	0.00	2.38	1.19	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	55.43	21.36	7.63	0.51	3.05	2.54	2.03	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	52.72	18.85	7.13	2.04	2.04	3.06	1.53	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	62.27	22.24	9.53	1.27	1.27	2.54	2.54	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	40.13	18.99	9.49	0.00	3.02	2.16	1.29	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	45.72	15.24	5.72	0.42	0.85	2.75	0.85	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	53.94	16.24	5.51	2.03	1.74	1.16	1.74	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	51.02	18.89	7.56	1.89	0.94	1.89	1.89	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	43.40	16.78	6.95	1.70	2.03	2.54	0.85	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	85.71	13.90	11.58	2.32	4.63	0.00	2.32	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	57.04	12.68	2.11	0.00	6.34	2.11	2.11	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	43.31	18.23	8.36	3.00	1.93	1.72	1.72	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	78.82	20.46	8.42	1.20	1.80	3.61	1.20	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	51.76	14.58	5.83	2.19	1.46	2.92	2.92	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	51.72	17.70	8.74	2.30	1.15	3.45	0.69	0.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	58.66	20.40	12.75	0.00	0.00	0.00	2.55	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	62.29	16.53	3.56	0.76	0.51	1.78	2.80	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	50.37	19.41	7.64	2.06	2.48	1.86	1.03	0.62
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	55.39	19.28	5.20	2.45	3.06	2.75	1.84	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	47.80	18.16	7.65	0.96	4.30	2.39	1.91	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	49.45	21.51	6.87	2.88	1.33	2.22	2.00	0.89
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	71.71	12.21	10.68	4.58	3.05	0.00	1.53	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	48.19	14.40	7.75	1.11	0.55	1.11	1.66	1.11
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	44.75	14.56	7.15	2.38	2.38	2.12	1.06	0.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	61.42	13.08	7.27	1.45	2.91	3.27	1.82	1.82
Astrocyte - cerebellum, donor1	11500-119F6	53.06	17.19	7.12	2.58	3.81	5.77	1.35	1.11
Astrocyte - cerebellum, donor2	11580-120F5	67.95	38.51	16.26	4.28	5.31	7.87	1.03	1.88
Astrocyte - cerebellum, donor3	11661-122F5	33.77	19.30	8.39	6.08	3.36	3.15	0.42	0.42
Astrocyte - cerebral cortex, donor1	11235-116D2	27.54	10.11	4.53	3.14	1.05	1.74	0.70	0.70
Astrocyte - cerebral cortex, donor2	11316-117D2	57.27	17.80	8.09	3.56	2.10	3.24	0.65	1.13
Astrocyte - cerebral cortex, donor3	11392-118C6	23.87	18.65	7.46	4.03	2.98	1.94	1.04	0.45
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	4.13	0.11	0.00	0.00	0.00	0.00	0.69	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	2.63	0.00	0.00	0.00	0.00	0.00	0.25	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	1.82	0.00	0.23	0.00	0.00	0.00	0.11	0.00
Basophils, donor1	12241-129G9	19.09	0.00	0.00	0.26	0.00	0.26	0.26	0.00
Basophils, donor2	12242-129H1	25.98	0.00	1.08	0.36	0.00	2.53	0.36	1.44
Basophils, donor3	12243-129H2	19.55	1.32	0.44	0.00	0.00	0.15	0.00	0.15
Bronchial Epithelial Cell, donor1	11511-119G8	13.58	11.86	8.62	0.86	2.16	0.43	0.00	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	58.52	54.86	19.20	2.74	5.03	0.46	0.46	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	21.52	14.35	14.35	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	65.28	32.64	23.22	0.63	0.63	1.88	0.00	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	61.97	42.21	24.33	1.04	2.50	2.50	0.42	0.42
Bronchial Epithelial Cell, donor6	11461-119B3	39.84	22.11	14.97	0.46	2.07	0.46	0.23	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	13.50	7.38	8.10	1.08	1.08	0.00	0.00	0.18
Burkitt's lymphoma cell line:DAUDI	10422-106C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	70.35	2.24	3.52	2.56	0.32	0.64	2.88	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	51.71	0.00	0.00	10.34	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	24.23	0.00	0.56	0.00	0.00	0.00	0.00	0.56
CD14+ Monocytes, donor2	11305-117B9	24.68	0.37	0.19	0.56	0.00	0.19	0.00	0.19
CD14+ Monocytes, donor3	11381-118B4	24.15	0.00	0.66	0.00	0.22	0.00	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	20.10	0.57	2.83	0.00	0.00	0.57	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	17.82	0.00	1.14	0.00	0.00	0.38	0.00	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	19.40	1.64	1.97	0.33	0.00	0.00	0.00	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	29.49	0.29	0.14	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	17.50	0.00	0.30	0.00	0.00	0.00	0.00	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	23.22	0.00	0.24	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	24.44	0.00	0.50	0.33	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	13.25	0.28	0.28	0.00	0.00	0.28	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	17.11	0.25	0.25	0.25	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	26.82	0.00	0.00	0.00	0.00	0.00	0.00	0.39
CD14+ monocytes - treated with BCG, donor2	11870-125B7	24.21	0.00	0.00	0.18	0.00	0.18	0.00	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	41.79	0.00	0.00	0.22	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	32.78	0.00	0.47	0.00	0.00	0.00	0.00	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	24.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	28.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	27.22	0.30	0.00	0.00	0.00	0.15	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	13.37	0.20	0.20	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	26.65	0.00	0.42	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	30.89	0.00	0.23	0.00	0.00	0.23	0.46	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	21.49	0.00	0.00	0.00	0.23	0.23	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	22.26	0.00	0.44	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	33.35	0.00	0.00	0.27	0.00	0.00	0.00	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	22.51	0.00	0.17	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	34.51	0.00	0.84	0.42	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	27.56	0.00	0.00	0.18	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	11.62	0.00	0.00	0.00	0.00	0.00	0.00	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	14.92	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	22.49	0.17	0.35	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	17.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	43.76	0.00	0.00	0.22	0.22	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	24.98	0.41	1.64	0.00	0.00	0.00	0.00	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	20.86	0.00	0.23	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	26.91	0.00	0.46	0.00	0.00	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	38.14	0.00	0.22	0.44	0.00	0.22	0.00	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	40.66	0.00	0.00	0.46	0.00	0.23	0.00	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	42.89	0.00	0.43	0.22	0.22	0.22	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	49.52	0.16	1.71	0.47	0.00	0.31	0.16	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	49.25	0.00	1.05	0.17	0.00	0.17	0.00	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	21.85	0.00	0.22	0.22	0.00	0.22	0.00	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	33.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	29.86	0.00	0.00	0.00	0.00	0.22	0.00	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	24.63	0.21	0.42	0.00	0.21	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	4.06	0.00	2.03	4.06	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	4.07	0.68	0.68	0.68	0.00	0.68	0.00	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	9.32	0.00	0.00	2.07	0.00	2.07	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	8.53	0.00	0.00	1.07	0.00	0.53	0.53	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	3.75	0.00	0.54	0.00	0.00	1.07	0.54	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	9.13	0.00	0.00	0.00	0.00	0.00	0.70	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	7.06	0.00	1.57	0.00	0.00	0.78	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	7.91	0.00	0.00	3.95	0.00	1.32	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	0.82	0.00	0.00	0.00	0.00	0.82	0.00	0.82
CD19+ B Cells, donor2	11624-122B4	2.18	0.00	0.00	0.73	0.00	0.73	0.00	0.73
CD19+ B Cells, donor3	11705-123B4	1.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	0.40	0.00	0.00	0.00	0.00	0.00	0.40	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	0.00	0.00	0.00	0.00	0.00	0.40	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	52.21	0.00	1.00	3.01	0.00	2.01	1.00	1.00
CD34+ Progenitors, donor2	11625-122B5	39.89	0.56	0.56	0.00	0.00	2.81	0.56	1.69
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	43.59	0.75	3.76	1.13	0.00	0.75	0.38	0.75
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	50.96	1.58	2.25	0.90	0.68	1.13	0.90	0.90
CD4+ T Cells, donor1	11225-116C1	6.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	1.84	0.00	0.00	0.00	0.00	0.61	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	3.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	6.13	0.26	0.00	0.26	0.00	0.00	0.51	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	8.98	0.00	0.45	0.00	0.00	0.67	0.22	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	9.77	0.29	0.00	0.00	0.00	0.00	0.29	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	14.22	0.00	0.00	0.95	0.00	0.95	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	14.05	0.00	0.70	1.40	0.00	0.70	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	9.89	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	2.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	4.41	0.00	0.00	0.00	0.00	0.00	0.34	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	3.55	0.00	0.16	0.16	0.00	0.00	0.16	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	3.59	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	3.49	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	0.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	8.85	0.00	0.42	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	13.71	0.21	1.04	0.00	0.00	0.42	0.21	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	9.69	0.33	0.00	0.33	0.00	0.33	0.33	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	13.05	0.00	0.54	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	16.08	0.00	0.54	0.00	0.00	0.00	0.54	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	8.97	0.00	1.79	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	5.01	0.00	0.00	0.19	0.19	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	6.93	0.00	0.00	0.00	0.00	0.22	0.22	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	3.15	0.00	0.21	0.21	0.00	0.00	0.21	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	2.02	0.00	0.51	0.00	0.00	0.00	0.00	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	4.77	0.00	0.43	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	0.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	6.93	0.00	0.49	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	4.62	0.00	0.92	2.77	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	5.58	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	7.20	0.55	0.55	0.00	0.28	0.28	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	8.34	0.00	0.98	0.00	0.00	0.74	0.00	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	7.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	9.31	0.00	0.36	0.72	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	9.69	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	0.98	0.00	0.00	0.33	0.00	0.33	0.00	0.00
CD8+ T Cells, donor2	11307-117C2	3.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells, donor3	11383-118B6	5.81	0.00	0.50	0.00	0.00	0.00	0.25	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	0.00	0.32	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	54.83	16.45	9.14	0.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	61.27	30.14	11.36	4.45	6.92	3.95	1.98	0.00
Cardiac Myocyte, donor3	11686-122I3	29.25	26.83	5.26	3.68	3.89	4.00	0.53	0.21
Chondrocyte - de diff, donor1	11261-116G1	63.44	31.89	10.05	1.39	1.39	2.43	0.00	0.69
Chondrocyte - de diff, donor2	11338-117F6	98.79	39.09	9.95	2.13	1.42	2.84	0.36	0.00
Chondrocyte - de diff, donor3	11410-118E6	75.66	38.12	15.36	2.62	2.62	1.71	0.46	0.34
Chondrocyte - re diff, donor2	11339-117F7	60.88	12.53	1.79	1.79	2.69	0.90	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	82.50	24.67	13.75	2.43	1.21	2.02	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	59.56	33.17	6.89	11.48	6.66	5.28	1.15	1.49
Ciliary Epithelial Cells, donor2	11323-117D9	35.49	34.20	9.41	11.12	9.83	4.92	1.28	1.07
Ciliary Epithelial Cells, donor3	11399-118D4	29.74	35.84	7.70	8.67	8.41	4.25	1.33	0.80
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	23.57	4.03	4.86	0.37	0.46	0.18	0.28	0.55
Corneal Epithelial Cells, donor1	11526-119I5	36.01	21.08	9.88	0.44	1.32	1.10	0.00	0.22
Corneal Epithelial Cells, donor2	11606-120I4	26.16	4.55	12.51	0.00	1.14	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	29.91	15.08	10.99	0.00	0.51	0.77	0.00	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	12.38	1.49	2.81	0.00	0.00	0.00	0.17	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	11.35	1.26	3.15	0.00	0.32	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	17.25	3.45	6.90	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	14.58	3.13	4.32	0.22	0.00	0.00	0.32	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	37.92	0.34	1.71	0.34	0.00	0.34	0.34	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	31.34	0.00	0.00	1.31	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	37.26	0.48	0.00	0.00	0.00	0.48	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	1.00	0.50	0.17	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	18.19	5.87	4.11	1.17	0.00	0.00	0.00	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	4.52	1.70	0.57	0.00	0.00	0.57	0.00	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	0.00	2.36	0.39	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	2.91	1.45	0.29	0.00	0.00	0.29	0.00	0.00
Endothelial Cells - Artery, donor2	11341-117F9	15.76	12.23	6.35	0.94	1.18	2.35	0.00	0.47
Endothelial Cells - Artery, donor3	11413-118E9	17.00	10.34	2.80	0.53	0.18	1.23	0.18	0.53
Endothelial Cells - Lymphatic, donor1	11236-116D3	6.65	2.88	0.44	0.44	0.44	0.22	0.00	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	4.56	1.83	1.83	0.61	0.30	0.00	0.00	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	4.23	1.41	0.85	0.56	0.00	0.28	0.00	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	2.97	5.35	4.16	0.59	0.59	0.89	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	5.73	8.85	5.21	0.52	0.52	1.04	0.00	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	2.13	4.54	3.54	0.85	0.57	0.43	0.00	0.28
Endothelial Cells - Thoracic, donor1	11266-116G6	1.60	1.20	0.40	0.00	0.00	0.80	0.00	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	30.40	22.54	6.81	1.05	1.05	1.05	1.05	1.57
Endothelial Cells - Umbilical vein, donor1	11243-116E1	24.48	8.32	4.10	0.62	0.99	1.86	0.12	0.87
Endothelial Cells - Umbilical vein, donor2	11324-117E1	16.73	7.17	3.48	0.43	0.22	0.87	0.22	0.65
Endothelial Cells - Umbilical vein, donor3	11400-118D5	22.84	6.72	4.03	0.49	0.24	1.71	0.00	0.73
Endothelial Cells - Vein, donor1	11267-116G7	18.20	14.79	13.65	2.28	2.28	2.28	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	18.86	13.27	4.89	3.49	0.70	1.40	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	19.94	10.99	2.98	1.57	0.47	3.30	0.00	0.47
Eosinophils, donor1	12244-129H3	0.00	0.00	0.00	0.00	0.00	15.25	0.00	0.00
Eosinophils, donor2	12245-129H4	1.65	0.00	0.00	0.00	0.00	1.65	0.00	0.00
Eosinophils, donor3	12246-129H5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	24.43	8.55	6.35	1.47	0.73	0.73	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	12.48	10.40	14.56	0.00	2.08	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	0.00	48.81	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	32.84	25.45	15.60	1.23	1.23	2.87	1.23	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	36.24	24.20	12.26	0.99	2.85	2.19	0.22	0.33
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	55.14	51.03	20.15	2.71	5.85	5.09	0.54	1.08
Fibroblast - Aortic Adventitial, donor1	11245-116E3	39.05	30.81	10.43	2.55	3.40	4.37	0.61	0.36
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	38.48	11.05	8.05	2.18	1.23	1.77	0.14	0.68
Fibroblast - Aortic Adventitial, donor2	11326-117E3	35.44	35.65	10.02	2.32	3.38	1.48	0.42	0.32
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	32.15	16.34	7.11	2.63	2.11	1.32	0.53	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	46.18	31.23	15.95	1.33	2.99	3.65	0.33	0.33
Fibroblast - Cardiac, donor1	11268-116G8	58.06	34.93	14.97	6.35	10.43	4.99	0.45	0.45
Fibroblast - Cardiac, donor2	11345-117G4	50.78	45.48	12.89	4.55	5.31	3.79	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	57.41	44.63	14.19	5.84	5.36	3.79	0.63	1.10
Fibroblast - Cardiac, donor4	11452-119A3	39.10	18.19	4.24	0.91	1.82	3.64	0.30	0.30
Fibroblast - Cardiac, donor5	11456-119A7	42.51	21.32	7.49	2.41	3.55	2.79	0.51	0.76
Fibroblast - Cardiac, donor6	11460-119B2	38.20	17.43	7.73	1.36	2.12	2.73	0.00	0.76
Fibroblast - Choroid Plexus, donor1	11492-119E7	36.58	24.12	4.82	2.41	3.35	3.62	1.21	0.40
Fibroblast - Choroid Plexus, donor2	11572-120E6	32.79	22.43	12.94	3.45	2.59	2.16	0.86	0.86
Fibroblast - Choroid Plexus, donor3	11653-122E6	26.37	27.83	4.39	2.93	5.86	1.46	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	60.43	32.52	15.45	8.07	3.00	3.92	0.00	0.69
Fibroblast - Conjunctival, donor3	11692-122I9	63.09	13.91	7.12	3.05	1.87	2.71	0.34	0.34
Fibroblast - Dermal, donor1	11269-116G9	60.10	24.65	7.28	2.82	3.29	0.94	0.00	0.70
Fibroblast - Dermal, donor2	11346-117G5	86.32	17.92	10.38	1.89	1.42	2.36	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	59.72	35.90	12.45	4.23	3.87	2.78	0.00	0.36
Fibroblast - Dermal, donor4	11450-119A1	72.69	16.96	10.40	1.58	2.03	1.70	0.00	0.68
Fibroblast - Dermal, donor5	11454-119A5	96.82	19.02	8.37	1.22	2.27	2.27	0.00	0.70
Fibroblast - Dermal, donor6	11458-119A9	107.20	19.98	10.40	1.30	1.30	3.90	0.49	0.32
Fibroblast - Gingival, donor1	11237-116D4	63.51	13.33	7.08	1.04	1.25	1.04	0.00	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	60.52	45.33	20.70	2.62	2.62	3.41	1.31	0.00
Fibroblast - Gingival, donor2	11318-117D4	97.52	30.44	15.55	2.24	3.29	3.29	0.26	0.66
Fibroblast - Gingival, donor3	11394-118C8	50.66	13.63	13.15	0.87	0.77	0.77	0.19	0.48
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	65.45	28.05	17.66	6.23	2.08	3.12	0.00	2.08
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	40.35	36.83	18.15	3.17	4.58	1.94	0.53	0.70
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	80.13	32.58	17.46	2.65	2.96	4.99	0.31	0.47
Fibroblast - Gingival, donor6 (control)	11922-125H5	83.30	24.61	17.85	2.16	1.76	2.57	0.68	0.41
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	52.23	74.81	25.76	1.41	4.94	3.53	0.35	0.71
Fibroblast - Gingival, donor7 (control)	11924-125H7	77.95	31.88	16.67	2.92	1.46	4.09	0.58	0.29
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	78.81	24.41	15.95	3.00	1.91	2.05	0.55	0.68
Fibroblast - Gingival, donor8 (control)	11926-125H9	65.93	30.06	18.54	2.08	2.30	4.50	0.55	0.66
Fibroblast - Gingival, donor9 (control)	11927-125I1	76.16	27.88	24.65	1.76	2.93	1.17	0.59	0.15
Fibroblast - Lung, donor1	11270-116H1	70.69	46.22	12.23	5.44	4.08	1.36	2.72	1.36
Fibroblast - Lung, donor2	11347-117G6	52.23	17.91	8.95	5.97	2.98	1.49	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	92.22	58.03	18.36	9.29	8.86	8.02	0.00	1.27
Fibroblast - Lymphatic, donor1	11506-119G3	76.64	18.33	10.83	0.83	1.67	0.83	0.00	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	41.96	18.18	8.39	0.00	2.80	2.80	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	46.18	24.35	11.20	1.40	1.68	1.68	0.84	0.84
Fibroblast - Mammary, donor1	11540-120B1	52.37	28.42	4.87	0.81	2.44	2.03	0.81	0.00
Fibroblast - Mammary, donor2	11620-122A9	71.90	35.95	35.95	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	47.65	41.69	11.91	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	115.61	22.89	9.70	2.72	2.91	0.97	0.19	0.78
Fibroblast - Periodontal Ligament, donor2	11319-117D5	79.78	22.30	9.71	1.97	1.67	2.12	0.30	0.76
Fibroblast - Periodontal Ligament, donor3	11395-118C9	49.26	13.16	9.18	0.31	0.92	0.92	0.61	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	53.05	24.81	14.12	0.38	2.29	0.76	0.76	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	79.11	41.85	17.55	3.78	4.86	2.70	1.35	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	52.77	32.36	17.51	1.39	2.44	1.28	0.23	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	52.06	26.53	8.18	3.65	3.32	4.86	0.88	0.66
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	52.22	26.21	13.82	2.64	2.84	2.24	0.41	0.81
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	92.21	24.72	10.69	0.67	3.34	0.67	0.00	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	76.70	23.33	8.70	5.93	3.56	1.19	0.40	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	59.34	9.72	9.53	1.59	1.59	2.58	0.20	0.60
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	69.27	23.98	8.17	3.91	3.73	1.60	0.18	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	54.79	29.37	6.31	4.34	3.15	1.38	0.39	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	55.96	20.76	8.72	4.21	0.90	1.50	0.60	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	61.42	26.99	10.90	2.91	4.32	2.16	0.11	0.00
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	55.17	13.92	11.89	2.28	2.28	1.77	0.76	0.00
Fibroblast - skin normal, donor1	11553-120C5	62.35	33.64	9.84	3.77	2.46	0.49	0.82	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	44.51	12.23	7.82	1.40	1.20	1.40	0.20	0.00
Fibroblast - skin normal, donor2	11561-120D4	57.36	17.58	10.45	1.81	2.71	3.01	0.10	0.40
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	62.26	16.02	10.28	2.12	0.91	2.42	0.60	0.60
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	81.35	32.72	8.20	4.31	5.96	2.57	0.25	0.33
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	79.49	29.23	11.45	9.06	6.50	4.10	0.51	0.68
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	51.89	9.20	8.87	1.64	0.66	1.31	0.00	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	66.58	19.39	8.52	2.02	2.34	2.88	0.00	0.00
Fibroblast - skin walker warburg, donor1	11554-120C6	77.26	31.21	10.63	4.22	6.24	4.22	0.17	0.51
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	47.36	30.58	20.86	3.76	5.65	2.35	0.47	0.47
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	110.80	0.00	22.16	22.16	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	1.74	0.87	6.10	0.00	0.00	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	39.18	13.35	9.19	0.52	0.87	0.17	0.17	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	35.39	12.49	6.25	1.04	0.78	1.30	0.00	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	26.32	9.96	4.09	0.26	0.26	0.77	0.00	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	67.37	49.76	4.59	19.90	9.95	16.84	22.20	4.59
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	92.52	51.05	10.21	20.42	8.29	12.76	17.23	4.47
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	42.50	43.65	17.12	10.27	7.70	4.56	15.12	1.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	12.96	20.68	8.55	17.10	14.34	4.69	0.28	1.10
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	14.38	16.44	7.31	6.16	2.28	1.14	1.60	0.23
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	38.44	52.70	11.29	8.12	8.92	3.76	11.10	1.78
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	11.63	17.45	9.52	13.48	10.84	3.70	0.00	2.11
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	12.07	12.07	7.18	2.94	4.24	0.98	0.33	0.98
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	60.14	44.22	11.06	8.40	6.19	6.19	18.13	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	32.08	13.57	8.76	10.60	5.94	4.66	6.64	0.28
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	27.95	12.81	5.79	6.53	4.93	4.56	4.56	0.49
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	32.77	16.12	5.64	8.33	4.84	4.57	8.33	1.07
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	34.32	16.35	5.58	9.29	7.06	3.22	0.87	0.62
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	51.36	16.47	5.95	7.75	5.54	5.40	0.69	0.55
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	46.96	22.36	5.90	9.56	5.69	2.24	4.27	0.41
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	37.88	15.52	4.79	9.13	6.85	3.19	1.60	2.28
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	36.87	11.46	6.10	5.61	5.98	5.11	0.87	0.50
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	37.16	15.52	4.59	9.18	4.81	3.28	0.87	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	34.28	15.07	7.68	10.34	5.32	4.14	0.89	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	29.73	11.29	4.45	8.90	4.29	3.81	0.79	1.43
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	30.16	15.19	4.69	7.82	6.48	3.13	2.01	0.67
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	31.86	13.31	6.45	9.07	3.23	2.42	1.21	1.01
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	35.12	10.86	5.09	6.28	4.24	4.92	0.51	0.85
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	40.08	13.39	3.55	6.92	4.34	2.75	1.51	0.35
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	26.64	13.11	4.06	5.72	3.54	1.56	0.21	0.62
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	27.67	10.25	3.59	7.34	4.10	2.22	0.34	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	26.11	8.74	6.75	5.53	4.09	2.55	0.77	0.66
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	32.11	11.48	3.58	4.74	4.58	3.33	1.08	0.50
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	32.06	11.43	2.65	4.70	3.47	4.29	1.84	1.02
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	30.33	11.55	6.40	7.43	5.36	2.27	1.03	1.03
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	24.79	11.64	4.38	6.11	3.92	1.84	0.35	0.58
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	33.52	11.34	5.67	4.00	4.34	2.33	1.00	0.67
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	28.66	14.55	8.16	4.85	4.41	1.54	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	23.25	9.22	7.50	5.90	5.04	2.95	0.86	0.74
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	29.99	11.18	7.94	5.51	3.57	3.57	0.81	0.81
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	25.98	9.62	8.66	4.17	3.21	1.92	0.32	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	29.85	7.86	8.53	3.88	2.94	2.46	0.38	0.38
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	24.68	9.17	5.38	3.01	2.85	1.58	0.00	0.79
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	33.75	6.99	7.60	4.87	2.43	2.13	0.91	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	34.50	7.94	5.96	3.87	2.40	1.67	0.31	0.52
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	27.44	10.76	6.37	3.73	3.51	2.20	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	35.91	9.54	6.73	2.81	2.81	1.68	0.56	0.84
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	33.52	9.17	8.52	3.61	2.59	1.94	0.09	0.65
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	43.85	11.77	7.49	2.41	3.21	2.67	1.07	0.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	48.04	10.10	6.73	2.14	1.99	1.38	0.15	0.46
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	37.57	9.46	8.94	3.37	2.46	1.68	0.39	0.78
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	26.84	11.39	7.86	2.44	1.63	1.36	0.00	0.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	34.66	16.59	7.93	2.40	5.16	2.03	0.55	0.37
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	36.19	11.62	8.33	4.82	5.48	2.41	0.00	1.32
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	16.86	5.95	8.93	2.98	2.98	0.00	0.00	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	41.95	15.04	4.35	5.54	4.75	2.64	0.13	0.79
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	39.54	15.54	9.48	6.66	5.04	2.62	1.21	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	20.08	6.86	4.07	2.80	1.52	0.76	0.00	0.25
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	38.02	19.11	4.58	7.56	5.57	4.78	6.17	1.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	28.35	16.79	7.86	9.55	5.70	4.31	7.09	0.46
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	32.94	18.62	6.55	9.00	6.96	3.48	6.14	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	47.57	21.28	4.07	12.52	4.38	6.88	10.33	1.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	46.90	20.63	6.50	10.45	2.54	6.50	7.06	1.13
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	27.67	12.91	3.23	5.07	4.15	4.15	3.69	1.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	59.40	22.27	4.95	12.37	4.95	7.42	4.95	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	37.52	21.27	5.42	8.90	5.80	7.35	5.80	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	59.37	27.28	6.42	6.42	11.23	6.42	4.81	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	38.25	17.39	12.17	10.43	8.69	3.48	0.00	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	28.32	20.51	6.84	8.79	3.91	4.88	2.60	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	34.18	23.06	7.00	6.18	3.71	5.35	4.53	2.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	26.66	23.33	3.33	13.33	3.33	10.00	3.33	6.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	28.52	13.14	5.03	7.27	4.19	5.87	1.96	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	29.09	16.34	5.56	7.19	4.25	4.58	2.94	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	16.78	18.45	5.03	11.74	10.07	5.03	2.52	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	28.63	17.81	7.63	8.91	5.09	7.95	1.59	1.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	26.49	11.21	5.43	12.23	7.81	6.45	0.68	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	41.76	14.62	22.97	4.18	6.26	8.35	2.09	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	30.35	16.61	8.02	15.46	10.88	2.29	0.57	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	34.63	18.65	4.74	12.14	8.29	5.62	1.78	0.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	49.13	23.72	6.78	5.08	15.25	6.78	1.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	56.75	23.20	8.70	14.08	4.14	6.21	0.41	2.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	38.66	15.19	5.98	10.59	4.14	7.82	1.38	2.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	79.03	5.27	5.27	5.27	0.00	15.81	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	43.82	12.69	5.00	7.30	4.23	3.08	1.15	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	56.39	19.56	4.89	9.13	6.19	6.19	2.28	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	50.83	25.42	5.35	7.36	7.36	8.03	1.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	40.45	23.50	6.16	12.71	10.02	8.09	0.77	1.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	53.41	20.20	6.16	13.35	9.24	7.19	1.03	1.71
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	32.30	19.88	7.45	7.45	12.42	14.91	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	35.39	19.82	12.27	11.32	8.97	5.66	1.42	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	44.06	22.33	6.03	18.71	6.64	7.85	0.60	1.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	50.87	26.96	9.66	6.61	9.66	5.09	1.02	2.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	43.87	18.75	6.38	9.17	9.57	4.39	1.20	1.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	49.34	28.12	7.40	11.84	9.37	6.91	0.49	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	53.12	23.61	5.90	10.62	1.18	3.54	1.18	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	60.68	19.84	9.92	7.58	8.17	7.58	0.58	1.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	40.38	24.14	6.58	11.85	7.90	2.19	0.44	2.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	38.99	15.26	6.78	5.93	3.39	4.24	0.85	3.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	37.61	14.92	4.18	8.95	7.76	6.57	4.18	1.79
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	53.86	16.01	6.79	10.68	6.31	8.25	4.37	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	87.88	31.96	29.67	2.28	2.28	2.28	3.42	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	53.64	34.93	22.04	2.91	4.57	1.66	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	104.57	40.48	33.73	0.00	2.25	5.62	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	54.87	17.44	7.61	3.17	2.22	1.27	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	76.03	17.96	7.94	2.51	2.09	2.92	0.84	0.84
Hep-2 cells mock treated, biol_rep1	11898-125E8	35.28	27.15	12.88	5.45	3.48	4.64	0.23	1.28
Hep-2 cells mock treated, biol_rep2	11899-125E9	36.29	22.62	14.85	3.71	4.22	4.90	0.17	1.18
Hep-2 cells mock treated, biol_rep3	11900-125F1	41.63	20.25	14.56	3.64	4.55	4.10	0.91	1.14
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	43.50	27.66	15.08	3.83	4.37	4.26	0.22	2.40
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	36.11	28.80	11.39	3.22	5.37	4.51	0.00	1.93
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	32.51	24.54	12.92	2.15	1.94	4.31	0.22	0.86
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	48.94	27.40	11.83	4.11	4.36	3.49	0.50	1.49
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	37.74	20.07	11.15	4.29	3.60	4.46	0.00	1.03
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	35.88	22.43	8.65	2.56	2.88	4.81	0.00	1.60
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	13.99	4.48	2.24	0.56	0.56	1.12	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	48.47	19.04	6.49	1.30	2.16	1.30	0.00	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	31.73	2.64	7.93	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	64.55	29.28	10.23	5.29	5.29	5.29	0.71	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	52.31	40.68	7.27	9.44	4.36	5.09	0.00	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	37.94	17.31	11.71	3.15	1.92	2.62	0.35	0.70
Hepatocyte, donor1	11523-119I2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	1.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	3.68	1.84	3.68	0.00	0.00	0.00	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	21.40	14.13	3.84	1.92	2.61	2.74	0.27	0.27
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	38.27	11.34	7.34	0.65	0.73	0.16	0.08	0.00
Keratinocyte - epidermal, donor2	11349-117G8	28.70	18.15	9.37	1.17	0.59	1.17	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	31.14	9.56	11.55	0.19	0.47	0.47	0.09	0.28
Keratinocyte - oral, donor1	11251-116E9	35.30	20.09	9.99	2.16	1.82	1.14	0.11	0.23
Keratocytes, donor1	11527-119I6	49.51	18.57	9.97	9.28	3.78	5.16	0.00	1.72
Keratocytes, donor2	11607-120I5	80.85	42.18	18.75	3.52	1.17	1.17	0.00	0.00
Keratocytes, donor3	11688-122I5	36.16	8.30	6.32	5.14	2.37	1.58	0.40	0.40
Krukenberg tumor cell line:HSKTC	10687-109F3	8.79	6.59	13.19	0.00	0.00	2.20	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	36.68	24.81	5.39	1.08	5.39	1.08	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	38.98	14.65	5.42	3.58	3.92	1.96	0.12	0.46
Lens Epithelial Cells, donor3	11690-122I7	20.99	16.35	4.74	2.32	3.13	3.63	0.61	0.50
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	2.13	5.69	3.20	0.59	0.71	0.59	0.12	0.59
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	4.47	3.63	5.86	1.40	0.84	1.12	0.28	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	1.26	2.99	2.05	0.47	0.47	0.94	0.00	0.47
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	1.61	5.91	3.23	1.61	0.00	2.15	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	4.41	6.30	4.10	1.26	0.00	0.63	0.00	0.95
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	1.29	5.50	2.59	0.65	0.22	0.86	0.00	0.22
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	0.82	5.75	2.87	1.64	0.82	1.23	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	3.79	6.83	4.05	2.02	0.25	1.26	0.00	0.51
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	1.27	5.35	2.11	0.70	0.70	0.14	0.00	0.84
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	0.40	5.54	1.98	1.58	0.40	0.79	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	4.46	7.95	2.71	0.58	0.39	1.16	0.00	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	0.93	5.37	2.04	0.74	0.74	0.19	0.00	0.93
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	4.53	3.48	1.05	0.70	1.05	1.05	0.00	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	2.39	5.96	4.05	0.48	0.24	0.72	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	1.51	3.57	3.02	0.55	0.27	0.96	0.00	0.27
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	1.54	2.77	1.54	0.62	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	3.12	6.86	3.12	0.94	0.62	1.25	0.00	0.94
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	0.91	5.49	2.38	0.55	0.37	0.73	0.00	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	1.65	6.25	1.97	0.33	0.99	0.66	0.33	0.66
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	5.56	4.39	4.39	0.29	0.88	1.17	0.00	0.88
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	1.74	5.73	2.74	1.49	0.25	1.24	0.00	0.75
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	0.48	3.88	3.39	0.00	0.00	1.45	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	3.77	5.66	3.23	0.27	0.00	2.15	0.00	0.81
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	1.36	4.84	2.27	0.45	0.15	0.61	0.00	0.30
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	3.63	4.15	2.59	0.00	0.00	1.04	0.00	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	3.77	5.44	1.88	0.84	0.00	0.84	0.21	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	1.35	4.21	2.11	0.60	0.30	0.60	0.00	0.45
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	0.00	6.88	4.82	2.06	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	3.20	5.64	2.63	0.56	0.38	1.13	0.00	0.94
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	1.06	5.09	2.65	0.53	0.32	0.74	0.00	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	3.88	4.85	3.88	0.97	0.97	0.97	0.00	0.97
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	3.64	2.32	3.97	1.65	0.66	1.32	0.00	0.66
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	0.99	3.47	2.73	0.62	0.50	0.87	0.00	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	2.22	4.07	6.29	1.11	0.00	0.37	0.00	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	3.71	5.68	1.73	0.25	0.00	0.49	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	1.10	3.99	3.30	0.69	0.00	0.55	0.00	0.41
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	1.61	3.86	2.25	0.64	0.96	0.64	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	2.74	5.17	3.65	1.22	0.00	2.13	0.00	0.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	1.12	3.64	2.24	0.56	0.00	0.56	0.00	0.70
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	1.07	2.13	2.84	0.71	0.36	0.36	0.00	0.71
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	3.88	8.73	1.45	0.97	1.45	0.97	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	1.40	6.38	2.96	0.31	0.62	0.78	0.00	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	1.07	4.66	2.15	0.72	0.36	0.36	0.00	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	2.94	5.55	3.59	1.63	0.65	1.63	0.00	0.98
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	1.41	6.12	2.83	0.47	0.47	0.94	0.00	0.47
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	2.48	5.20	2.35	0.62	0.50	0.99	0.00	0.62
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	2.05	4.87	1.54	0.77	0.00	1.02	0.00	0.77
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	2.09	4.18	3.58	0.60	0.00	0.30	0.00	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	18.92	0.00	1.37	0.23	0.00	0.23	0.46	0.00
Macrophage - monocyte derived, donor2	11313-117C8	9.36	1.28	1.65	0.00	0.00	0.00	0.00	0.18
Macrophage - monocyte derived, donor3	11389-118C3	22.28	1.05	3.80	0.00	0.00	0.00	0.00	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	40.36	7.43	4.78	0.53	1.59	1.59	0.53	0.53
Mallassez-derived cells, donor2	11929-125I3	36.29	9.67	8.56	0.48	0.32	0.95	0.16	0.32
Mallassez-derived cells, donor3	11930-125I4	36.28	9.31	6.12	1.39	0.83	0.56	0.14	0.28
Mammary Epithelial Cell, donor1	11273-116H4	13.55	13.55	8.17	0.70	1.20	0.50	0.10	0.70
Mammary Epithelial Cell, donor2	11350-117G9	20.56	13.03	8.40	1.16	0.58	1.16	0.00	0.00
Mammary Epithelial Cell, donor3	11422-118F9	32.67	17.96	12.72	1.25	1.50	1.25	0.00	0.25
Mast cell - stimulated, donor1	11487-119E2	10.85	0.68	0.00	2.03	0.00	0.00	0.00	0.00
Mast cell, donor1	11563-120D6	29.63	0.32	1.51	0.32	0.11	0.00	0.54	0.00
Mast cell, donor2	11565-120D8	82.32	1.78	6.54	1.49	0.00	1.19	0.30	0.59
Mast cell, donor3	11566-120D9	147.68	2.70	8.10	0.90	0.45	0.68	0.90	0.68
Mast cell, donor4	11567-120E1	86.34	0.71	9.40	0.53	0.00	0.71	0.53	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	26.28	0.55	1.11	0.00	0.00	0.11	0.55	0.00
Mast cell, expanded and stimulated, donor8	11942-126A7	64.79	2.33	2.92	0.58	0.00	0.00	0.58	0.00
Mast cell, expanded, donor5	11939-126A4	51.62	0.34	1.49	0.34	0.11	0.23	0.69	0.23
Mast cell, expanded, donor8	11941-126A6	42.68	0.84	2.51	1.17	0.00	1.17	1.00	0.33
Melanocyte - dark, donor1	11502-119F8	1.29	6.87	3.98	0.70	0.10	1.09	0.00	0.30
Melanocyte - dark, donor2	11582-120F7	68.87	22.15	12.81	3.11	4.15	3.81	1.04	1.73
Melanocyte - dark, donor3	11663-122F7	39.34	7.75	7.97	0.65	1.16	0.80	0.14	0.29
Melanocyte - light, donor1	11274-116H5	45.13	5.41	7.52	0.24	0.24	1.65	0.47	0.00
Melanocyte - light, donor2	11351-117H1	43.68	10.24	14.33	1.36	0.68	2.05	0.00	0.00
Melanocyte - light, donor3	11423-118G1	40.76	12.14	16.48	0.00	0.87	1.73	0.87	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	44.25	8.43	15.51	1.15	0.94	0.52	0.00	0.42
Melanocyte, donor2 (MC+2)	12739-135I3	44.91	14.52	10.76	1.61	1.34	1.88	0.00	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	22.23	5.36	8.84	1.34	0.54	0.27	0.00	0.00
Meningeal Cells, donor1	11493-119E8	46.52	24.56	6.70	2.73	2.36	4.59	0.50	0.74
Meningeal Cells, donor2	11573-120E7	22.01	26.41	6.60	3.52	0.88	4.40	1.76	0.00
Meningeal Cells, donor3	11654-122E7	41.00	19.97	6.19	1.47	1.55	2.04	0.65	0.49
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	89.25	31.08	11.12	11.69	4.56	7.13	1.71	1.71
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	27.07	27.17	5.23	2.31	4.33	2.82	0.30	0.60
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	149.81	35.48	22.34	5.26	3.94	3.94	1.31	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	130.82	26.16	6.54	3.92	1.31	2.62	1.31	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	68.17	27.27	14.35	2.15	0.72	2.87	0.00	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	24.35	21.81	8.68	2.96	2.33	2.75	0.21	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	19.10	23.62	10.05	2.01	2.01	3.52	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	105.04	33.18	10.77	9.45	7.03	4.83	1.32	1.54
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	64.29	34.34	8.04	16.07	4.38	6.58	0.73	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	86.96	38.67	12.28	10.43	3.48	4.71	0.61	1.02
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	90.45	14.27	5.54	5.40	4.02	2.63	0.14	0.69
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	49.44	31.60	14.50	3.35	3.35	3.35	0.37	0.74
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	36.97	16.58	6.32	2.63	3.68	1.58	0.00	0.13
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	65.28	19.29	10.09	4.15	2.37	1.19	0.30	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	53.72	21.02	16.35	7.01	2.34	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	69.80	21.77	11.53	1.28	4.48	3.20	0.64	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	86.84	22.68	7.80	1.42	2.13	5.67	0.00	1.06
Mesenchymal stem cells - hepatic, donor0	11218-116B3	39.09	18.76	9.38	2.50	1.25	2.50	0.31	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	63.86	21.05	14.51	4.35	3.63	5.08	0.00	0.73
Mesothelial Cells, donor1	11247-116E5	51.97	18.03	12.73	0.80	1.33	1.59	0.27	0.27
Mesothelial Cells, donor2	12156-128G5	39.04	19.52	9.01	0.00	3.50	1.50	0.50	0.50
Mesothelial Cells, donor3	11402-118D7	37.58	21.32	12.00	1.01	1.45	0.94	0.07	0.43
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	8.10	1.35	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	6.16	0.25	0.74	0.00	0.00	0.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	9.72	0.29	1.47	0.00	0.29	0.29	0.29	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	6.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	5.27	0.00	0.93	0.31	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	8.92	0.62	0.21	0.21	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	6.95	0.00	6.95	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	10.26	1.25	1.75	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	6.98	0.47	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	11.38	0.41	2.44	0.00	0.41	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	5.94	0.79	2.38	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	2.65	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	8.74	1.14	2.28	0.00	0.00	0.38	0.38	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	2.63	0.00	1.32	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	7.64	0.64	0.85	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	9.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	3.58	1.49	0.89	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	3.35	0.00	1.68	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	4.77	0.25	1.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	8.79	0.95	1.66	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	3.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	7.37	1.84	1.61	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	5.26	0.42	1.26	0.21	0.00	0.00	0.21	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	5.50	0.00	1.63	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	3.22	0.64	1.07	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	4.67	0.22	0.89	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	3.29	0.22	0.66	0.00	0.00	0.00	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	2.53	1.52	1.01	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	6.63	0.00	3.31	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	2.17	0.00	0.54	0.27	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	2.65	0.29	0.29	0.29	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	8.72	1.09	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	4.81	0.96	1.44	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	5.60	0.00	1.20	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	4.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	4.51	0.00	1.50	0.50	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	2.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	4.82	0.00	0.44	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	0.00	0.00	1.10	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	5.76	0.64	1.28	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	3.97	0.50	0.50	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	2.09	0.00	0.70	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	2.21	0.00	0.00	0.00	0.00	0.00	2.21	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	17.44	1.03	0.68	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	4.38	1.31	1.31	0.00	0.00	0.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	10.65	0.36	0.71	0.00	0.00	0.00	0.00	0.36
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	15.99	0.28	1.68	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	5.82	0.83	0.83	0.00	0.00	0.00	0.00	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	15.73	0.58	1.17	0.58	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	11.76	0.60	0.60	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	7.10	0.83	1.25	0.00	0.42	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	14.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	16.62	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	9.11	2.28	3.41	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	15.34	0.41	1.66	0.00	0.00	0.00	0.14	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	22.03	1.04	1.81	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	10.72	1.72	1.72	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	13.34	0.00	0.64	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	13.34	0.27	1.87	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	37.72	0.90	1.50	0.30	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	24.44	0.57	0.99	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	30.58	0.96	2.55	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	14.15	1.33	1.77	0.00	0.00	0.22	0.22	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	20.86	0.00	1.14	0.00	0.00	0.00	0.00	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	24.15	0.57	0.85	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	28.76	1.72	3.93	0.00	0.00	0.00	0.00	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	18.25	0.00	1.30	0.00	0.65	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	32.64	0.29	1.47	0.29	0.29	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	38.64	2.59	5.19	0.00	0.00	0.29	0.00	0.58
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	54.40	0.00	1.24	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	44.37	0.89	1.79	0.00	0.00	0.00	0.30	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	33.90	0.00	7.53	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	14.26	0.00	1.78	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	20.37	0.00	0.99	0.33	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	19.99	0.00	0.00	1.05	0.00	1.05	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	14.43	0.59	1.19	0.20	0.00	0.20	0.20	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	3.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	7.14	0.00	0.75	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	10.65	0.80	1.33	0.00	0.00	0.00	0.27	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	21.38	0.23	0.68	0.00	0.00	0.34	0.11	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	8.10	0.00	1.47	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	13.19	0.00	0.73	0.00	0.00	0.00	0.37	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	4.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	24.58	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	3.86	0.00	3.86	3.86	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	19.19	1.01	6.06	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	8.01	0.42	2.11	0.42	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	9.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	3.81	0.00	0.64	0.00	0.00	0.00	0.00	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	9.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	6.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	5.71	0.00	11.42	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	0.00	3.26	6.52	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	0.00	4.75	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	12.55	12.55	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	27.58	24.78	6.25	2.15	3.66	4.31	0.22	1.29
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	36.06	17.77	4.70	2.61	2.09	4.18	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	46.72	16.69	7.34	0.67	0.67	0.00	0.00	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	47.16	22.12	14.19	0.83	2.09	1.25	0.42	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	40.31	18.82	12.93	0.57	2.09	3.61	0.95	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	55.85	9.58	14.36	1.60	0.00	3.19	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	37.40	10.20	6.12	0.00	2.04	1.36	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	9.19	16.54	14.70	1.84	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	49.81	16.32	10.46	0.42	2.09	0.84	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	67.41	25.10	11.16	0.70	0.93	3.02	0.46	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	48.10	19.46	8.92	0.54	1.62	0.27	0.81	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	55.08	14.51	9.25	0.42	0.84	0.63	0.63	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	11.13	0.00	0.00	0.00	11.13	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	69.99	14.39	12.41	1.99	1.99	1.99	0.50	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	45.20	13.26	11.10	1.35	1.35	2.44	0.54	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	65.06	21.53	10.65	0.68	2.27	0.45	0.23	0.45
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	44.25	24.01	7.51	2.12	3.10	1.14	0.00	0.65
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	49.03	14.76	7.84	1.09	1.09	0.73	0.36	0.55
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	63.12	18.03	5.83	1.06	2.12	1.06	1.06	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	63.63	10.81	5.40	1.80	1.20	0.00	0.60	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	28.88	14.77	7.22	1.64	2.95	0.98	0.66	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	47.97	22.93	7.81	1.30	2.76	0.98	0.49	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	38.80	12.52	6.35	1.41	1.23	0.53	0.00	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	71.03	16.88	11.25	0.70	4.92	0.70	0.70	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	75.39	18.85	12.87	1.38	3.68	0.00	0.00	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	65.55	28.60	9.00	3.86	7.39	1.61	0.96	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	23.11	18.97	8.97	2.76	3.10	1.72	0.69	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	10.11	5.06	7.59	0.00	2.53	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	34.53	13.59	8.24	0.89	1.56	0.89	0.45	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	54.19	24.56	6.77	2.12	3.81	1.69	0.42	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	58.15	17.09	8.31	1.90	1.90	1.42	0.47	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	56.23	27.47	6.01	3.43	4.29	3.00	0.43	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	18.06	0.00	0.00	0.00	9.03	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	41.32	12.66	4.33	1.33	2.67	1.00	0.67	0.67
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	34.72	12.62	6.76	1.80	1.80	1.35	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	34.52	23.41	7.14	3.97	1.59	2.78	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	76.15	18.57	10.22	0.00	2.79	1.86	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	52.22	25.73	9.84	3.41	4.16	1.89	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	34.22	24.44	6.84	2.28	4.89	2.61	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	40.53	12.64	5.23	1.74	2.18	0.87	0.87	0.87
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	30.30	13.57	4.98	0.45	1.36	0.90	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	35.28	18.52	8.82	2.65	0.88	2.65	0.00	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	79.78	17.29	5.32	3.99	0.00	1.33	0.00	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	56.55	20.83	1.98	2.48	1.98	1.49	0.99	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	35.60	17.23	2.68	3.06	2.68	2.68	0.38	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	57.46	16.33	9.68	5.44	3.02	2.12	0.30	0.60
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	34.48	16.58	5.08	1.77	2.43	1.99	0.22	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	31.17	18.30	3.39	3.39	2.71	1.36	0.00	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	45.99	0.00	10.22	5.11	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	74.38	23.78	7.32	1.83	1.83	2.44	0.61	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	36.51	19.51	4.72	1.89	2.20	2.52	0.31	0.63
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	45.70	8.17	3.33	0.61	1.21	1.21	0.61	0.61
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	53.80	15.82	13.45	0.00	0.00	0.00	0.79	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	27.21	20.41	13.60	4.53	2.27	1.13	1.13	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	20.23	5.06	10.12	5.06	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	37.39	16.40	7.83	1.12	1.12	1.49	0.25	0.25
Myoblast, donor2	11322-117D8	44.69	39.70	11.89	5.18	3.45	2.69	0.96	0.58
Myoblast, donor3	11398-118D3	49.78	17.83	7.74	0.84	0.17	2.02	0.00	0.34
NK T cell leukemia cell line:KHYG-1	10777-110G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Natural Killer Cells, donor1	11230-116C6	3.38	0.00	0.31	0.00	0.00	0.00	0.00	0.00
Natural Killer Cells, donor2	11311-117C6	2.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Natural Killer Cells, donor3	11387-118C1	4.60	0.00	0.37	0.00	0.00	0.18	0.18	0.00
Neural stem cells, donor1	11275-116H6	27.58	7.62	3.27	6.17	1.45	3.99	0.00	0.00
Neural stem cells, donor2	11352-117H2	7.70	1.93	0.00	1.93	0.00	0.00	0.00	0.00
Neurons, donor1	11494-119E9	12.52	10.24	2.28	0.00	0.00	3.41	0.00	0.00
Neurons, donor2	11574-120E8	14.09	3.08	3.30	0.22	0.00	0.00	0.22	0.22
Neurons, donor3	11655-122E8	6.58	1.64	4.11	0.82	0.00	0.00	0.00	0.82
Neutrophils, donor1	11233-116C9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	1.83	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	79.91	22.80	8.67	6.89	4.39	1.66	1.07	0.47
Nucleus Pulposus Cell, donor2	11409-118E5	91.82	26.05	13.35	6.19	5.86	2.93	0.65	0.65
Nucleus Pulposus Cell, donor3	11462-119B4	57.96	20.06	8.62	4.81	4.61	1.80	0.00	0.60
Olfactory epithelial cells, donor1	11933-125I7	39.09	28.22	14.04	3.99	1.79	2.06	0.28	0.28
Olfactory epithelial cells, donor2	11934-125I8	39.52	28.37	16.94	5.21	3.76	3.04	0.43	0.29
Olfactory epithelial cells, donor3	11935-125I9	36.78	33.03	15.44	2.50	3.75	2.16	0.23	0.45
Olfactory epithelial cells, donor4	11936-126A1	43.73	40.42	15.49	2.92	2.53	1.36	0.97	0.10
Oligodendrocyte - precursors, donor1	11496-119F2	45.74	23.47	9.63	1.81	3.61	1.81	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	51.26	29.14	7.66	4.89	5.32	2.55	0.43	0.00
Osteoblast - differentiated, donor2	11353-117H3	75.45	41.15	11.43	4.57	5.72	4.57	1.14	0.00
Osteoblast - differentiated, donor3	11425-118G3	75.73	30.41	10.55	6.21	6.21	2.48	0.00	0.00
Osteoblast, donor1	11277-116H8	120.78	78.96	14.85	22.87	15.83	14.46	2.15	2.54
Osteoblast, donor2	11354-117H4	51.97	42.14	5.62	6.32	4.92	2.11	1.40	0.70
Osteoblast, donor3	11426-118G4	62.38	54.92	16.71	8.89	5.69	6.75	0.71	1.24
Pancreatic stromal cells, donor1	11249-116E7	59.47	22.58	10.19	2.86	2.27	2.02	0.34	0.25
Pericytes, donor1	11491-119E6	69.88	16.47	6.79	5.12	4.01	3.78	0.67	0.56
Pericytes, donor2	11571-120E5	41.65	31.69	12.45	4.07	5.43	2.04	0.68	1.13
Pericytes, donor3	11652-122E5	56.36	30.92	11.60	3.66	2.85	3.46	0.20	0.20
Perineurial Cells, donor1	11499-119F5	31.08	18.54	8.48	2.71	3.16	2.71	0.00	0.23
Perineurial Cells, donor2	11579-120F4	50.70	23.46	7.91	3.22	4.14	3.59	1.38	0.64
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	15.30	0.64	0.32	0.64	0.00	0.00	0.00	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	20.81	0.24	0.00	0.24	0.00	0.24	0.00	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	13.46	0.00	0.26	0.13	0.00	0.26	0.13	0.00
Placental Epithelial Cells, donor1	11278-116H9	99.73	15.55	12.20	1.67	0.72	4.54	0.00	1.20
Placental Epithelial Cells, donor2	11355-117H5	79.84	38.81	18.85	2.22	1.11	5.54	0.00	1.11
Placental Epithelial Cells, donor3	11427-118G5	57.52	26.31	25.13	4.91	3.53	3.53	0.39	1.18
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	25.95	33.23	12.03	1.27	2.22	2.85	0.63	0.63
Preadipocyte - breast, donor1	11467-119B9	24.39	20.26	6.57	2.25	0.94	1.69	0.19	0.56
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	21.80	8.88	8.88	0.78	0.52	1.70	0.52	0.39
Preadipocyte - breast, donor2	11328-117E5	22.97	23.42	16.89	1.58	1.35	2.25	0.23	0.23
Preadipocyte - omental, donor1	11468-119C1	21.21	21.84	10.23	0.96	0.85	1.07	0.32	0.11
Preadipocyte - omental, donor2	11329-117E6	25.32	23.57	9.17	3.06	1.75	2.18	0.00	0.00
Preadipocyte - omental, donor3	11403-118D8	21.77	22.49	10.31	0.72	1.43	2.58	0.29	0.00
Preadipocyte - perirenal, donor1	11469-119C2	48.23	44.29	12.80	0.98	2.95	6.89	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	58.66	43.00	13.51	3.69	3.69	6.76	0.31	0.92
Preadipocyte - subcutaneous, donor2	11356-117H6	56.13	23.73	11.51	2.48	1.59	4.43	0.71	0.53
Preadipocyte - subcutaneous, donor3	11428-118G6	43.93	44.61	16.35	3.75	2.04	3.24	0.17	0.51
Preadipocyte - visceral, donor1	11280-116I2	62.78	19.65	6.99	1.12	1.30	2.33	0.19	0.19
Preadipocyte - visceral, donor2	11357-117H7	42.80	28.07	9.66	0.92	1.38	1.84	0.92	0.00
Preadipocyte - visceral, donor3	11429-118G7	48.69	22.99	10.66	1.25	1.57	3.87	0.21	0.52
Prostate Epithelial Cells (polarized), donor1	11253-116F2	0.15	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Prostate Epithelial Cells, donor2	11331-117E8	22.21	21.40	11.10	0.54	0.81	0.68	0.00	0.27
Prostate Epithelial Cells, donor3	11404-118D9	9.43	3.98	4.90	0.24	0.31	0.00	0.00	0.00
Prostate Stromal Cells, donor1	11254-116F3	39.30	21.07	8.43	2.39	2.16	2.51	0.11	0.23
Prostate Stromal Cells, donor2	11332-117E9	39.98	37.29	11.48	5.02	3.05	3.23	0.18	1.08
Prostate Stromal Cells, donor3	11405-118E1	43.07	29.09	13.97	2.61	1.67	2.19	1.15	0.52
Renal Cortical Epithelial Cells, donor1	11516-119H4	50.00	18.98	10.58	5.11	4.38	2.55	0.00	0.73
Renal Cortical Epithelial Cells, donor2	11596-120H3	42.49	16.01	8.25	2.22	2.63	1.18	0.14	0.21
Renal Epithelial Cells, donor1	11517-119H5	110.58	39.06	21.81	12.17	12.17	5.58	0.00	2.54
Renal Epithelial Cells, donor2	11597-120H4	79.67	32.72	21.34	4.98	3.56	6.40	0.00	0.71
Renal Epithelial Cells, donor3	11678-122H4	48.59	16.62	9.42	2.54	2.86	1.48	0.11	0.42
Renal Glomerular Endothelial Cells, donor1	11514-119H2	11.57	4.09	6.81	0.68	0.68	1.36	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	14.55	7.14	3.91	0.54	0.81	2.56	0.00	0.94
Renal Glomerular Endothelial Cells, donor3	11675-122H1	29.75	15.32	11.10	2.66	1.11	2.44	0.00	0.67
Renal Glomerular Endothelial Cells, donor4	11783-124B1	16.64	17.97	7.99	2.00	2.00	2.66	0.00	2.00
Renal Mesangial Cells, donor1	11518-119H6	50.62	30.37	11.00	5.72	8.58	4.62	0.44	1.10
Renal Mesangial Cells, donor2	11598-120H5	41.38	29.47	13.17	8.15	7.52	2.51	1.25	0.63
Renal Mesangial Cells, donor3	11679-122H5	50.49	33.84	19.14	8.04	6.94	5.27	3.33	0.83
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	61.20	27.65	13.96	1.88	2.15	2.42	0.00	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	35.84	15.60	17.71	1.69	2.11	0.84	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	80.61	28.73	16.58	6.94	7.91	4.82	0.39	0.77
Retinal Pigment Epithelial Cells, donor0	11215-116A9	72.60	12.96	10.11	2.07	3.11	1.04	0.26	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	42.64	23.31	7.67	7.11	5.12	5.68	1.71	1.14
Retinal Pigment Epithelial Cells, donor2	11608-120I6	45.28	23.67	11.32	5.15	9.26	2.06	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	48.17	9.53	3.76	5.02	1.51	2.01	0.00	0.75
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	15.10	2.67	2.00	0.27	0.13	0.53	0.00	0.13
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	33.95	5.36	8.93	1.79	0.00	0.89	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	17.06	2.75	3.85	1.10	1.10	1.10	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	16.82	5.80	6.96	1.74	0.58	0.58	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	30.69	4.81	4.29	0.26	1.17	0.52	0.00	0.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	27.61	8.24	8.04	0.70	1.19	1.59	0.60	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	42.38	10.37	6.36	1.90	1.67	1.23	0.11	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	31.88	6.95	6.33	1.61	1.86	1.86	0.50	0.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	36.25	10.02	9.91	2.21	2.21	1.28	0.12	0.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	36.29	9.94	10.40	1.16	1.85	1.62	0.46	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	29.71	5.89	6.16	0.96	1.78	0.82	0.27	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	29.35	6.20	7.87	1.21	1.66	0.61	0.45	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	42.47	10.21	5.91	1.25	2.15	1.79	0.00	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	36.87	7.03	6.46	1.15	1.43	0.72	0.00	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	33.05	10.52	9.98	1.72	1.82	1.29	0.11	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	38.06	9.96	10.40	1.99	1.77	0.89	0.44	1.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	28.10	6.88	6.69	0.57	0.57	0.96	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	28.69	7.73	6.43	1.12	1.02	1.30	0.65	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	36.45	6.20	5.07	1.32	1.32	1.50	0.75	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	24.95	4.78	6.24	0.66	1.33	0.93	0.00	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	25.21	8.08	7.20	1.65	1.27	0.97	0.58	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	28.83	8.02	7.64	1.15	0.76	1.72	0.57	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	30.97	5.66	5.98	1.50	1.39	0.96	0.43	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	25.23	11.21	7.57	0.28	0.28	1.68	0.28	1.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	25.46	10.42	7.69	0.85	1.71	1.37	0.85	1.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	30.81	6.75	7.66	0.91	0.91	1.09	0.18	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	28.94	9.57	10.55	2.08	1.96	0.86	0.74	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	35.46	10.88	11.42	2.42	1.88	0.94	0.27	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	37.74	8.02	9.43	1.89	1.65	1.18	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	27.18	11.31	7.74	2.58	1.19	1.59	0.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	34.61	11.93	9.82	0.94	2.57	0.70	0.23	1.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	30.69	8.50	6.43	2.07	1.66	0.41	0.21	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	32.74	6.64	8.41	1.33	1.77	0.44	0.22	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	26.95	10.65	5.85	1.25	1.67	1.04	0.63	0.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	30.82	8.08	7.40	0.94	1.08	1.21	0.54	0.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	21.97	7.32	5.62	1.36	0.68	0.68	0.17	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	30.08	11.18	7.13	2.12	1.16	1.93	0.19	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	35.25	8.42	8.25	1.89	1.38	1.20	0.34	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	22.36	8.23	7.13	0.82	1.10	1.23	0.96	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	27.58	9.03	7.39	1.48	1.48	0.99	0.33	1.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	31.53	5.11	7.84	0.51	2.22	1.19	0.17	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	28.41	7.69	8.73	1.48	2.07	1.78	0.30	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	25.86	7.20	8.26	3.20	0.80	1.87	0.80	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	20.33	6.50	4.70	1.38	1.52	1.24	0.69	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	27.38	10.00	11.43	0.95	1.90	1.43	0.71	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	24.39	9.88	11.08	1.81	2.02	0.60	0.00	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	25.52	7.72	7.91	1.98	2.17	1.04	0.47	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	28.30	10.83	10.48	1.75	0.35	0.70	0.35	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	23.57	5.74	5.44	0.91	0.60	1.51	0.30	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	29.37	12.12	9.79	1.84	2.33	1.22	0.12	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	25.18	6.84	4.51	2.04	0.87	0.44	0.15	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	38.33	5.48	11.56	1.83	1.83	1.22	0.61	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	30.14	8.74	12.96	2.11	1.21	0.90	0.00	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	28.05	10.63	7.46	4.52	2.94	1.36	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	29.65	11.68	11.68	2.40	1.80	1.50	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	28.22	7.44	8.86	3.66	2.13	1.42	0.35	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	32.02	13.87	13.66	3.20	2.99	2.56	0.21	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	21.03	7.81	13.82	2.40	3.00	1.20	0.60	0.00
Schwann Cells, donor1	11498-119F4	104.76	37.61	18.43	3.95	4.89	4.89	0.56	1.13
Schwann Cells, donor2	11578-120F3	68.05	40.83	20.41	6.80	10.21	6.80	3.40	0.00
Schwann Cells, donor3	11659-122F3	56.30	19.94	16.87	2.63	3.72	3.51	0.22	0.88
Sebocyte, donor1	11220-116B5	31.22	7.12	7.12	0.55	0.00	0.55	0.00	1.10
Sebocyte, donor2	11301-117B5	16.08	12.87	5.97	0.92	0.46	0.00	0.46	0.00
Sebocyte, donor3	11378-118B1	31.95	12.37	11.75	0.41	1.03	0.82	0.00	0.00
Sertoli Cells, donor1	11255-116F4	26.51	31.48	11.60	1.66	0.00	4.97	1.66	0.00
Sertoli Cells, donor2	11333-117F1	53.66	39.54	11.30	2.82	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	94.22	22.52	7.83	4.40	2.99	3.17	0.18	0.97
Skeletal Muscle Cells, donor2	11358-117H8	30.36	33.97	8.67	4.34	2.89	2.17	0.72	0.00
Skeletal Muscle Cells, donor3	11430-118G8	150.49	64.37	35.95	5.02	9.20	5.02	0.84	3.34
Skeletal Muscle Cells, donor4	11451-119A2	61.89	27.96	6.91	5.97	4.56	5.66	0.47	0.31
Skeletal Muscle Cells, donor5	11455-119A6	62.88	22.59	9.96	3.42	5.20	5.05	0.00	0.89
Skeletal Muscle Cells, donor6	11459-119B1	70.18	26.63	9.85	2.92	4.16	2.15	0.15	1.23
Skeletal Muscle Satellite Cells, donor1	11240-116D7	91.61	18.77	7.18	3.65	2.39	1.89	0.88	0.63
Skeletal Muscle Satellite Cells, donor2	11321-117D7	63.21	25.68	8.99	4.14	2.85	3.14	0.14	0.43
Skeletal Muscle Satellite Cells, donor3	11397-118D2	59.43	29.07	9.52	4.17	5.36	3.87	0.20	0.89
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	35.72	21.40	4.04	5.64	2.27	5.14	0.76	0.34
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	168.64	49.22	20.99	3.62	4.34	5.07	0.72	2.90
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	100.72	46.23	9.36	12.38	8.39	10.04	1.24	1.24
Skin - palm, donor1	10286-104F7	29.55	0.00	2.69	0.00	0.00	0.00	2.69	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	30.27	18.74	7.64	1.15	2.16	0.14	0.14	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	49.07	22.08	13.90	1.64	0.82	0.82	0.82	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	26.23	16.62	8.05	1.17	1.04	0.52	0.00	0.39
Small Airway Epithelial Cells, donor1	11256-116F5	20.16	10.98	5.28	1.39	0.83	1.53	0.00	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	17.16	14.63	5.77	1.83	0.98	0.70	0.14	0.28
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	30.45	17.76	9.94	1.69	1.48	1.69	0.42	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	9.89	5.85	5.10	0.82	0.52	0.30	0.00	0.15
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	58.32	29.62	14.19	2.16	4.32	1.54	0.31	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	26.24	9.56	4.67	0.22	1.33	1.33	0.22	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	76.42	44.67	11.17	2.94	2.94	5.29	1.18	1.18
Smooth Muscle Cells - Aortic, donor1	11283-116I5	58.78	21.22	6.85	1.77	2.65	3.09	0.00	0.66
Smooth Muscle Cells - Aortic, donor2	11360-117I1	60.64	32.29	7.48	3.94	3.94	4.73	0.79	1.18
Smooth Muscle Cells - Aortic, donor3	11432-118H1	88.85	49.44	10.82	0.77	2.32	6.18	0.00	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	84.06	29.02	17.01	5.00	5.00	3.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	76.92	39.39	11.98	1.46	3.86	4.52	0.93	0.80
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	62.06	28.82	11.75	2.44	1.55	2.22	0.22	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	52.62	27.14	7.94	1.41	3.71	3.46	0.90	0.38
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	42.98	18.56	5.21	1.95	2.60	2.93	0.33	0.65
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	31.60	16.24	5.61	2.66	4.13	3.84	0.30	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	25.06	18.08	9.11	1.28	2.42	1.85	0.43	0.28
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	62.63	26.35	7.32	4.88	3.58	4.88	0.49	0.49
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	45.06	6.70	6.09	1.83	1.83	1.52	0.91	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	95.47	39.15	14.90	3.54	4.80	3.03	1.26	1.01
Smooth Muscle Cells - Carotid, donor2	11362-117I3	36.72	42.84	24.48	0.00	6.12	6.12	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	76.77	36.72	24.80	2.38	1.43	3.34	1.43	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	49.55	17.99	6.64	1.77	1.92	1.33	0.29	0.59
Smooth Muscle Cells - Colonic, donor2	11320-117D6	34.01	13.56	7.10	2.58	4.09	2.15	0.65	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	38.10	19.73	9.87	3.57	3.36	3.57	0.10	0.31
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	62.80	35.58	12.53	1.86	3.71	3.56	1.24	0.15
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	72.22	62.52	9.70	7.55	7.55	6.47	2.16	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	53.50	23.91	14.05	1.79	1.79	2.39	0.30	0.60
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	70.67	34.82	8.19	6.15	5.46	7.85	0.00	1.02
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	59.76	16.88	7.70	3.69	3.14	1.65	0.31	0.55
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	72.36	33.51	13.89	1.91	1.71	1.11	0.20	0.50
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	46.65	25.71	10.92	2.28	2.05	4.78	0.46	0.46
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	74.27	52.53	16.30	3.62	6.04	6.64	0.60	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	61.46	22.52	9.27	5.56	2.38	6.62	0.26	3.18
Smooth Muscle Cells - Prostate, donor1	11257-116F6	39.28	19.71	9.72	1.73	2.40	2.26	0.00	0.40
Smooth Muscle Cells - Prostate, donor2	11335-117F3	38.19	30.68	11.14	3.63	2.50	2.63	0.75	0.50
Smooth Muscle Cells - Prostate, donor3	11465-119B7	53.27	9.89	4.57	1.27	1.01	1.01	0.25	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	63.63	41.76	11.76	2.26	2.56	3.32	1.36	0.45
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	91.52	45.76	22.51	1.50	2.25	2.25	0.75	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	85.29	19.38	21.97	0.00	2.58	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	72.55	64.18	13.95	3.26	2.79	8.84	0.93	0.93
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	76.24	51.50	8.08	7.07	3.53	6.56	5.05	1.51
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	69.57	38.55	12.54	2.51	4.70	4.39	1.57	0.63
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	55.75	15.04	6.78	2.36	3.24	1.18	0.00	0.59
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	64.81	17.91	6.58	2.33	2.42	4.58	0.42	0.75
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	47.18	12.61	7.94	2.34	1.87	2.80	0.00	0.93
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	60.59	32.09	8.92	1.58	3.02	4.17	0.14	0.72
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	81.08	38.50	16.83	2.55	5.10	4.59	0.76	1.27
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	72.96	42.87	11.85	4.32	6.02	7.52	0.56	1.13
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	56.32	13.42	5.31	1.68	2.79	1.82	0.28	0.28
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	50.61	24.63	8.38	3.10	4.86	2.51	0.08	0.42
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	58.09	19.05	15.71	1.90	3.33	1.90	0.95	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	56.52	36.21	10.03	3.18	2.20	5.38	0.24	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	34.91	31.37	8.40	2.87	1.55	5.08	0.44	0.44
Smooth Muscle Cells - Uterine, donor3	11466-119B8	76.36	15.51	10.53	1.76	2.93	2.05	0.88	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	48.20	17.30	14.97	1.36	1.75	0.19	0.78	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	25.12	10.05	5.82	0.53	0.79	0.79	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	34.22	5.95	4.46	1.49	0.37	0.37	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	57.85	15.45	8.26	1.80	2.87	0.36	0.72	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	45.14	16.75	5.96	0.85	0.85	1.70	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	58.29	19.30	8.27	3.54	1.18	4.73	0.00	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	36.57	8.89	9.65	0.76	0.76	1.27	1.02	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	49.91	13.58	14.77	1.60	1.60	0.00	0.80	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	48.91	17.14	12.54	3.34	1.67	2.09	1.25	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	55.46	17.88	12.83	2.75	3.21	2.29	0.46	1.38
Synoviocyte, donor1	11291-117A4	43.09	22.22	7.91	4.38	1.35	1.68	0.17	0.17
Synoviocyte, donor2	11368-117I9	91.86	35.20	17.27	1.68	0.67	0.84	0.17	0.17
Synoviocyte, donor3	11440-118H9	75.51	21.45	16.09	0.00	1.34	0.22	0.67	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	119.35	42.52	8.93	8.93	7.15	5.72	0.71	1.79
Trabecular Meshwork Cells, donor2	11612-122A1	55.50	35.68	11.89	3.96	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	79.88	39.83	14.82	9.49	6.48	6.71	0.93	1.39
Tracheal Epithelial Cells, donor1	11292-117A5	35.84	11.11	7.17	1.00	0.72	1.29	0.00	0.36
Tracheal Epithelial Cells, donor2	11369-118A1	41.75	39.82	16.62	0.77	1.93	1.16	0.00	1.93
Tracheal Epithelial Cells, donor3	11441-118I1	56.69	34.93	18.33	0.57	1.15	1.15	0.57	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	16.61	1.97	2.21	0.12	0.37	0.37	0.00	0.00
Urethra, donor2	10319-105A4	50.36	5.40	19.78	0.00	0.00	0.00	1.80	0.00
Urothelial Cells, donor1	11520-119H8	32.68	15.14	8.50	1.59	1.06	0.27	0.00	0.00
Urothelial Cells, donor2	11600-120H7	26.04	10.01	7.21	0.80	3.20	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	31.17	17.88	10.54	1.38	1.60	0.23	0.00	0.00
Urothelial cells, donor0	11216-116B1	30.09	18.28	8.69	0.67	1.78	0.89	0.00	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	11.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	4.29	0.00	1.43	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	9.58	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	9.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	12.20	0.00	0.58	0.58	0.00	0.00	0.00	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	13.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	11.01	0.00	0.00	0.00	0.00	0.00	0.00	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	9.13	0.00	0.91	0.00	0.00	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	19.74	22.21	5.55	8.02	4.81	5.55	3.33	1.23
Wilms' tumor cell line:HFWT	10597-108E3	35.20	14.96	12.32	10.56	1.76	5.28	3.52	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	22.90	7.82	6.98	2.51	1.68	0.84	0.56	0.00
achilles tendon, donor2	10292-104G4	12.40	4.13	2.07	2.07	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	9.29	0.46	1.63	0.46	0.00	0.23	0.93	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	17.92	0.36	0.59	0.12	0.12	0.36	2.73	0.47
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	41.32	1.41	2.81	1.12	0.28	1.69	1.41	0.56
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	10.62	0.00	0.27	0.00	0.00	0.00	0.54	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	59.93	16.30	10.13	2.64	1.32	2.64	0.88	0.88
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	53.09	4.08	3.27	0.41	0.00	0.41	2.04	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	66.01	0.00	4.27	1.94	0.00	0.39	3.49	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	23.40	3.90	3.90	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	31.14	3.95	2.09	1.39	0.23	0.70	2.79	0.23
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	49.45	0.78	1.81	0.78	0.00	0.00	0.26	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	68.09	0.58	2.05	0.58	0.00	0.00	0.29	0.29
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	18.13	0.00	1.39	0.46	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	33.02	1.67	4.34	0.00	0.67	0.00	0.00	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	1.86	7.43	1.86	0.00	0.00	1.86	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	6.78	7.16	6.78	1.13	1.13	0.38	3.39	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
adipose tissue, adult, pool1	10010-101C1	20.32	1.09	2.17	0.00	0.00	0.31	0.00	0.00
adipose, donor1	10184-103D4	12.90	6.45	3.52	5.86	2.93	2.35	0.00	2.35
adipose, donor2	10185-103D5	14.19	16.22	10.95	7.30	5.27	1.22	0.00	0.41
adipose, donor3	10186-103D6	16.07	16.61	7.62	5.99	1.91	1.91	1.63	0.27
adipose, donor4	10187-103D7	33.80	22.54	8.67	7.80	6.07	5.20	4.33	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	26.20	48.45	15.47	4.58	5.68	3.63	1.26	3.31
adrenal gland, adult, pool1	10081-102A9	87.30	0.00	10.91	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	36.44	35.02	21.44	2.86	2.50	3.22	1.43	0.00
amniotic membrane cells, donor1	12235-129G3	29.21	3.25	11.36	0.00	0.93	0.46	0.00	0.23
amniotic membrane cells, donor2	12236-129G4	41.25	21.64	36.52	1.69	3.04	1.01	0.68	0.00
amniotic membrane cells, donor3	12237-129G5	28.28	6.19	9.72	0.29	0.29	0.00	0.29	0.00
amygdala - adult, donor10196	10167-103B5	13.04	2.37	1.19	1.19	0.00	0.00	0.00	0.00
amygdala, adult, donor10252	10151-102I7	12.37	1.01	2.43	0.41	0.00	0.41	0.00	0.20
amygdala, newborn, donor10223	10360-105E9	11.94	0.32	1.29	0.32	0.00	0.97	0.00	0.97
anaplastic carcinoma cell line:8305C	10428-106D5	44.31	19.61	10.06	3.69	3.57	2.04	0.25	0.51
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	66.63	1.99	3.75	0.22	0.00	0.88	0.22	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	23.72	21.71	5.34	6.01	5.01	4.01	3.34	0.33
aorta, adult, pool1	10052-101G7	51.78	7.65	13.73	0.78	0.39	0.39	0.39	0.00
appendix, adult	10189-103D9	15.52	1.94	2.72	0.00	0.00	1.16	0.00	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	5.85	3.44	2.06	0.00	0.34	0.00	0.69	0.00
artery, adult	10190-103E1	23.10	1.36	1.36	0.00	1.36	0.00	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	100.68	14.92	4.35	4.06	4.49	1.45	1.16	0.43
b cell line:RPMI1788	10427-106D4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	39.95	20.81	7.77	1.11	1.66	2.50	0.28	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	47.63	15.98	9.82	0.69	1.39	1.69	0.40	0.50
bile duct carcinoma cell line:TFK-1	10496-107C1	4.02	0.17	0.50	0.00	0.00	0.00	0.00	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	55.92	1.68	0.56	1.12	0.00	0.56	0.56	0.56
bladder, adult, pool1	10011-101C2	53.34	2.50	6.95	0.65	0.11	0.76	0.00	0.00
blood, adult, pool1	10053-101G8	8.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	41.10	22.27	11.99	0.86	1.71	0.86	0.00	0.00
bone marrow, adult	10192-103E3	17.55	3.37	2.70	1.35	0.00	2.02	0.00	0.00
brain, adult, donor1	10084-102B3	8.20	1.03	3.08	0.00	2.05	1.03	0.00	0.00
brain, adult, pool1	10012-101C3	7.46	1.67	1.56	0.89	0.33	0.11	0.00	0.22
brain, fetal, pool1	10085-102B4	10.69	0.00	2.67	0.00	0.00	5.34	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
breast, adult, donor1	10080-102A8	25.89	1.26	5.05	0.63	0.00	0.63	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	27.31	7.75	6.73	2.03	1.14	0.89	0.51	0.51
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	38.65	11.44	5.88	4.95	3.09	0.62	1.24	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	22.10	2.99	5.53	0.92	0.23	0.23	0.46	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	6.78	8.23	6.29	2.91	1.21	1.69	0.00	0.24
carcinoid cell line:NCI-H1770	10703-109H1	4.70	1.41	0.94	0.47	0.00	0.94	0.00	0.47
carcinoid cell line:NCI-H727	10735-110B6	41.78	7.55	7.44	1.31	0.77	0.98	0.22	0.22
carcinoid cell line:SK-PN-DW	10719-109I8	4.44	2.22	2.22	0.00	0.00	0.00	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	22.89	7.72	9.05	3.99	1.06	2.93	0.27	1.06
caudate nucleus - adult, donor10196	10177-103C6	19.57	0.00	1.15	1.15	0.00	0.00	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	13.22	2.68	2.18	1.17	0.67	0.17	0.00	0.00
caudate nucleus, adult, donor10258	10379-105H1	6.88	1.53	0.00	0.00	0.00	0.00	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	13.92	0.37	1.83	0.00	0.00	0.73	0.00	0.37
cerebellum - adult, donor10196	10173-103C2	8.74	2.91	2.91	0.00	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	9.18	2.56	1.92	1.07	0.00	0.21	0.21	0.00
cerebellum, adult, pool1	10083-102B2	6.21	3.45	2.07	0.34	0.69	0.34	0.00	0.00
cerebellum, newborn, donor10223	10357-105E6	8.30	1.66	0.83	0.83	0.83	0.83	0.00	0.83
cerebral meninges, adult	10188-103D8	14.62	3.53	2.77	0.76	1.26	0.25	0.25	0.00
cerebrospinal fluid, donor2	10294-104G6	10.23	1.46	2.92	0.73	0.73	0.73	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	26.89	7.33	4.17	6.61	2.16	3.02	0.14	1.29
cervical cancer cell line:ME-180	10553-107I4	3.48	5.30	7.13	2.49	0.33	2.82	0.00	0.50
cervix, adult, pool1	10013-101C4	62.05	9.03	9.45	0.73	0.42	1.78	0.31	0.10
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	15.68	5.23	3.92	0.00	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	3.48	7.46	3.23	2.36	1.24	1.37	0.00	0.25
choriocarcinoma cell line:SCH	10785-110H2	0.12	13.18	7.76	2.09	1.48	0.62	0.12	0.74
choriocarcinoma cell line:T3M-3	10618-108G6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
chorionic membrane cells, donor1	12238-129G6	21.08	5.70	7.41	0.85	1.14	0.28	0.00	0.00
chorionic membrane cells, donor2	12239-129G7	29.93	28.74	15.51	2.78	3.78	2.88	0.20	0.89
chorionic membrane cells, donor3	12240-129G8	12.64	7.14	6.59	0.00	0.00	0.55	0.00	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	70.50	6.34	4.61	2.50	0.19	1.34	0.19	0.58
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	8.66	0.00	1.48	0.42	0.21	0.42	0.21	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	20.07	1.04	0.78	1.30	0.00	0.26	0.78	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	25.60	8.69	9.14	1.83	0.69	0.23	0.23	0.69
clear cell carcinoma cell line:TEN	10636-108I6	32.10	9.20	2.08	5.73	2.08	1.39	2.60	0.52
colon carcinoma cell line:CACO-2	10513-107D9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
colon carcinoma cell line:COLO-320	10420-106C6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
colon, adult, donor1	10082-102B1	19.04	1.19	3.57	0.00	0.00	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	29.73	2.82	4.47	0.12	0.12	0.24	0.24	0.00
colon, fetal, donor1	10070-101I7	8.03	4.33	3.71	0.00	0.00	1.24	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	32.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	75.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
corpus callosum, adult, pool1	10042-101F6	11.28	1.77	1.88	0.44	0.11	0.55	0.00	0.11
cruciate ligament, donor2	10295-104G7	23.50	4.05	4.86	0.00	0.00	0.00	0.81	0.00
diaphragm, fetal, donor1	10069-101I6	16.85	10.43	4.01	0.00	0.00	1.61	0.00	0.00
diencephalon, adult	10193-103E4	6.24	0.96	1.68	0.48	0.00	0.24	0.00	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	8.46	1.28	0.51	0.26	0.00	0.51	0.26	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	17.09	6.02	1.44	2.17	0.48	2.65	0.24	0.72
ductus deferens, adult	10196-103E7	27.91	1.50	7.48	0.50	0.50	0.50	1.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	14.40	8.64	5.76	1.44	0.00	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	20.60	5.89	5.89	1.47	0.00	0.00	0.00	0.00
dura mater, adult, donor1	10041-101F5	52.36	9.50	8.09	0.74	0.50	1.49	0.99	0.33
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	73.28	30.87	13.99	10.88	2.89	8.66	0.22	2.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	49.01	14.62	11.46	4.59	3.58	3.44	0.57	1.43
embryonic pancreas cell line:1B2C6	10604-108F1	9.87	5.55	9.87	1.23	1.23	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	17.25	15.74	7.87	2.72	0.91	0.30	0.30	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	15.75	10.50	4.63	0.62	1.54	0.31	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	14.45	1.31	9.19	1.31	1.31	1.31	0.00	1.31
endometrial carcinoma cell line:OMC-2	10497-107C2	25.47	9.05	3.69	4.36	1.34	4.02	0.67	0.67
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	29.90	10.87	11.60	2.54	1.09	0.54	0.18	0.18
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	35.70	67.70	21.07	9.01	7.08	2.41	7.24	0.80
epidermoid carcinoma cell line:A431	10426-106D3	21.12	13.12	7.11	1.89	0.44	0.22	0.00	0.22
epidermoid carcinoma cell line:Ca Ski	10431-106D8	52.46	19.03	7.92	6.49	3.74	1.87	0.33	0.55
epididymis, adult	10197-103E8	37.47	7.95	7.33	0.21	0.42	0.21	1.05	0.00
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	18.81	18.98	11.71	1.06	1.60	1.24	0.53	0.89
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	12.98	17.70	4.72	2.75	1.18	1.18	0.00	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	36.43	17.82	10.22	3.41	1.70	3.54	0.26	1.05
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	32.48	17.22	10.92	2.76	1.77	2.85	0.30	0.89
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	36.97	17.36	11.88	2.24	2.13	3.81	0.67	1.12
esophagus, adult, pool1	10015-101C6	33.66	2.87	5.10	0.42	0.21	0.53	0.00	0.11
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	4.88	10.14	2.88	2.00	0.50	2.38	0.13	0.88
eye - muscle inferior rectus, donor1	10272-104E2	38.63	0.00	9.66	0.00	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	23.15	4.21	0.00	0.00	0.00	2.10	0.00	0.00
eye - muscle medial, donor2	10299-104H2	10.42	2.98	0.00	0.00	0.00	0.00	2.98	0.00
eye - muscle superior, donor2	10297-104G9	22.93	3.44	5.73	2.29	0.00	1.15	2.29	0.00
eye - vitreous humor, donor1	10268-104D7	11.66	1.46	2.91	0.00	0.00	1.46	0.00	0.00
eye, fetal, donor1	10054-101G9	18.56	5.08	5.08	0.51	0.25	0.76	0.00	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	20.77	6.80	3.08	0.51	0.90	0.38	0.26	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	50.10	18.04	8.07	1.42	1.42	1.19	0.00	0.00
frontal lobe, adult, pool1	10040-101F4	5.54	1.60	1.50	0.75	0.47	0.38	0.28	0.09
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	24.02	12.61	4.20	4.80	2.40	1.80	0.30	0.90
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	17.83	0.64	0.82	0.00	0.00	0.00	0.18	0.00
gall bladder, adult	10198-103E9	36.94	7.00	7.97	0.72	0.24	1.21	1.21	0.00
gamma delta positive T cells, donor1	11937-126A2	2.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	2.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	70.34	43.51	18.59	10.14	9.72	5.49	0.84	1.90
gastric adenocarcinoma cell line:MKN45	10612-108F9	27.85	6.38	6.77	2.13	0.58	2.32	0.00	0.39
gastric cancer cell line:AZ521	10549-107H9	14.76	21.64	8.20	3.61	1.31	1.31	2.46	0.33
gastric cancer cell line:GSS	10560-108A2	17.39	30.20	17.39	1.83	1.83	0.92	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	10.51	5.71	5.48	3.43	0.46	0.46	0.00	0.00
giant cell carcinoma cell line:LU65	10487-107B1	15.38	4.59	4.02	2.64	0.34	0.34	0.00	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	62.14	22.11	7.70	8.68	6.30	1.82	0.42	0.56
glassy cell carcinoma cell line:HOKUG	10688-109F4	19.70	6.73	6.24	1.25	1.25	0.00	0.25	0.75
glioblastoma cell line:A172, tech_rep1	10444-106F3	37.47	9.61	8.97	0.53	0.53	1.48	0.21	0.21
glioblastoma cell line:A172, tech_rep2	10444-106F3	35.39	8.57	6.74	0.70	0.56	0.70	0.14	0.56
glioblastoma cell line:T98G	10485-107A8	36.42	14.79	8.39	3.53	2.10	3.97	0.99	0.88
glioma cell line:GI-1	10413-106B8	54.77	9.37	7.32	2.64	2.05	2.34	0.29	0.00
globus pallidus - adult, donor10196	10175-103C4	9.48	1.46	2.19	0.73	0.00	0.00	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	9.52	1.46	1.71	0.49	0.24	0.00	0.24	0.00
globus pallidus, adult, donor10258	10367-105F7	19.17	0.00	5.48	0.00	0.00	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	10.66	1.60	0.00	1.07	0.00	0.00	0.53	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	36.71	0.00	0.00	0.00	0.00	2.45	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	32.79	0.00	0.00	0.00	0.00	0.00	10.93	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	141.12	0.00	0.00	5.23	0.00	5.23	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	31.04	20.48	9.28	1.60	2.56	1.92	0.00	0.00
hIPS +CCl2, biol_rep1	14383-156B9	33.06	21.12	5.51	9.18	5.05	6.43	13.31	0.92
hIPS +CCl2, biol_rep2	14384-156C1	24.69	22.41	5.94	8.69	4.12	5.03	10.97	0.46
hIPS +CCl2, biol_rep3	14385-156C2	27.05	27.70	8.37	10.95	3.86	5.15	10.31	0.00
hIPS, biol_rep1	14380-156B6	60.37	35.93	14.37	14.37	4.31	7.19	21.56	0.00
hIPS, biol_rep2	14381-156B7	46.64	42.52	10.29	7.54	2.06	6.17	16.46	1.37
hIPS, biol_rep3	14382-156B8	19.86	1.10	1.10	1.10	0.00	1.10	2.21	0.00
hairy cell leukemia cell line:Mo	10712-109I1	25.29	1.44	1.15	0.57	1.15	0.29	5.17	0.00
heart - mitral valve, adult	10205-103F7	26.61	3.89	4.19	0.60	0.00	0.00	0.00	0.00
heart - pulmonic valve, adult	10206-103F8	22.23	2.61	4.18	0.52	0.52	0.26	0.52	0.00
heart - tricuspid valve, adult	10207-103F9	19.98	4.16	5.83	0.83	0.00	0.00	0.00	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	4.90	4.29	8.77	0.20	0.61	0.41	0.20	0.41
heart, adult, diseased, donor1	10051-101G6	8.09	1.28	1.70	0.43	0.00	0.00	0.00	0.43
heart, adult, pool1	10016-101C7	11.27	2.76	4.14	0.00	0.00	0.23	0.00	0.00
heart, fetal, pool1	10046-101G1	13.14	6.06	4.52	0.62	0.51	1.85	0.21	0.62
hepatic mesenchymal tumor cell line:LI90	10778-110G4	24.06	19.44	8.33	0.62	2.78	1.85	0.00	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	9.51	3.57	2.38	3.57	1.19	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
hepatoma cell line:Li-7	10484-107A7	57.28	10.90	8.67	6.56	1.89	3.78	0.56	0.89
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
hippocampus - adult, donor10196	10169-103B7	12.30	0.95	0.00	0.00	0.00	0.00	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	10.61	2.25	3.06	2.25	0.41	0.61	0.00	0.00
hippocampus, adult, donor10258	10374-105G5	7.47	1.00	0.50	0.00	1.00	0.00	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	5.64	1.76	1.06	0.35	0.35	0.00	0.35	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	50.05	38.45	13.43	14.04	6.71	5.49	21.97	1.22
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	43.98	45.16	8.25	8.44	4.91	3.34	14.33	1.96
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	40.62	37.07	7.62	7.36	5.84	4.82	14.98	0.25
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	17.48	10.15	6.20	12.41	9.59	2.82	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	13.94	14.98	8.00	12.39	7.23	3.10	0.00	0.77
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	21.64	18.22	5.69	9.87	7.21	3.80	0.00	1.52
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	8.76	7.01	3.80	2.92	1.46	0.58	0.00	0.58
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	7.97	10.34	4.74	4.95	1.51	0.86	0.22	0.86
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	11.26	10.43	5.00	2.50	2.50	2.09	0.83	1.25
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	18.71	13.97	4.03	3.32	2.37	2.60	1.18	0.71
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	22.02	16.07	6.27	4.66	2.89	2.09	1.77	0.32
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	24.91	14.81	6.06	4.04	1.35	3.37	2.02	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	39.90	36.15	6.73	7.51	7.04	2.50	10.33	0.78
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	43.23	28.00	7.37	6.88	7.37	3.93	14.74	0.98
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	58.47	20.07	6.11	8.73	2.62	1.75	22.69	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	16.04	13.94	3.05	9.16	5.15	3.82	0.38	0.76
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	15.70	11.77	3.92	6.98	9.59	3.05	0.00	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	17.99	13.49	4.50	8.00	3.00	2.00	0.00	1.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	14.69	8.85	6.78	6.03	1.13	1.70	0.00	0.75
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	12.28	9.09	7.28	4.55	5.00	0.00	0.00	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	14.41	9.08	4.70	5.95	3.45	0.94	0.31	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	26.78	16.00	5.72	5.55	5.39	1.80	0.82	0.98
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	23.22	14.23	4.94	6.39	5.52	2.32	1.16	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	26.31	18.53	11.36	8.37	5.08	2.09	0.30	0.90
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	46.93	47.85	9.42	11.27	7.94	5.54	14.23	1.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	34.80	43.36	8.27	9.41	7.70	4.85	12.84	1.43
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	63.70	40.42	9.39	9.80	10.62	8.17	22.05	1.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	17.25	14.79	5.63	14.08	6.69	4.22	0.00	1.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	16.47	15.84	5.38	9.50	6.33	4.75	0.95	1.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	20.28	20.58	6.66	17.55	7.87	1.82	0.61	2.42
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	19.13	15.00	8.27	5.69	3.10	1.55	0.52	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	24.57	18.60	9.30	9.96	3.32	2.66	0.66	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	21.55	14.62	9.24	5.64	2.82	2.57	0.51	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	32.47	15.85	4.09	7.41	6.14	2.81	1.02	1.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	34.08	10.60	8.33	4.54	6.06	5.30	1.51	1.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	44.02	27.56	11.76	9.75	4.03	3.70	1.34	1.68
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	45.40	40.81	8.21	12.80	8.45	3.14	12.08	1.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	58.83	34.32	9.36	12.03	10.70	6.24	20.05	1.78
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	45.37	55.12	12.68	16.59	8.78	6.83	13.66	0.98
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	14.36	15.59	8.25	8.25	5.20	2.14	0.00	0.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	19.52	6.51	3.25	9.76	0.00	3.25	0.00	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	15.89	13.90	4.30	10.59	4.30	4.63	0.33	1.32
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	9.30	9.85	7.66	2.19	2.19	1.09	0.55	1.64
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	14.11	5.79	5.79	5.07	3.26	1.45	0.00	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	6.05	5.34	4.98	4.98	2.14	1.42	0.36	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	22.67	8.35	1.19	2.39	5.97	1.19	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	28.30	13.14	5.28	5.69	3.25	2.44	0.68	1.22
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	29.63	17.24	6.20	3.77	4.31	1.62	0.54	1.08
immature langerhans cells, donor1	11904-125F5	4.36	0.24	0.97	0.97	0.00	1.21	0.00	0.00
immature langerhans cells, donor2	11905-125F6	0.79	0.79	2.38	1.58	0.00	0.00	0.00	0.79
insula, adult, pool1	10039-101F3	7.48	2.93	1.61	1.32	0.47	0.09	0.09	0.00
keratoacanthoma cell line:HKA-1	10791-110H8	2.28	0.00	1.63	0.00	0.00	0.00	0.00	0.00
kidney, adult, pool1	10017-101C8	24.93	4.41	8.01	0.90	0.70	0.20	0.20	0.10
kidney, fetal, pool1	10045-101F9	22.71	15.49	10.33	2.83	2.55	1.70	1.84	0.99
large cell lung carcinoma cell line:IA-LM	10509-107D5	83.08	7.10	2.70	3.98	4.40	2.27	0.43	0.43
large cell lung carcinoma cell line:NCI-H460	10839-111E2	34.28	14.93	11.89	4.29	1.66	3.46	0.28	0.41
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	28.63	4.77	2.75	2.75	1.83	2.75	0.00	0.55
left atrium, adult, donor1	10079-102A7	21.25	1.63	4.36	0.00	0.00	0.00	0.00	0.54
left ventricle, adult, donor1	10078-102A6	8.60	2.02	3.54	0.00	0.00	0.00	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	38.31	27.91	3.83	6.84	4.38	7.93	2.74	0.55
leiomyoma cell line:10964C	10569-108B2	59.64	26.94	13.29	2.16	2.16	3.95	0.00	0.36
leiomyoma cell line:15242A	10570-108B3	47.83	14.13	4.89	1.63	2.17	3.26	0.00	0.00
leiomyoma cell line:15425	10571-108B4	56.09	20.88	10.68	1.70	1.21	1.46	0.24	0.49
leiomyosarcoma cell line:Hs 5.T	10722-110A2	57.14	0.00	19.05	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	71.10	25.09	18.82	5.23	2.09	3.14	0.00	3.14
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
liposarcoma cell line:KMLS-1	10782-110G8	62.17	10.93	9.84	1.09	2.03	0.31	0.47	0.16
liposarcoma cell line:SW 872	10726-110A6	29.73	16.45	9.50	4.14	3.17	3.66	1.58	0.73
liver, adult, pool1	10018-101C9	1.62	0.65	1.13	0.00	0.00	0.16	0.00	0.00
liver, fetal, pool1	10086-102B5	5.64	0.94	6.58	0.00	0.94	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	14.29	2.33	0.58	0.44	0.00	0.00	0.00	0.00
locus coeruleus, adult, donor10252	10165-103B3	13.29	0.55	0.92	0.37	0.00	0.18	0.00	0.18
locus coeruleus, adult, donor10258	10375-105G6	11.29	1.69	1.97	0.28	0.28	0.28	0.00	0.00
locus coeruleus, newborn, donor10223	10362-105F2	7.99	2.10	1.26	0.42	0.42	1.68	0.00	0.00
lung adenocarcinoma cell line:A549	10499-107C4	30.03	1.25	4.98	0.42	0.55	0.00	0.00	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	26.20	7.58	9.65	0.69	0.69	0.69	0.00	0.69
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	76.85	34.54	27.95	5.67	6.06	1.19	2.77	0.66
lung, adult, pool1	10019-101D1	28.23	3.90	4.25	0.24	0.24	0.35	0.12	0.47
lung, fetal, donor1	10068-101I5	27.97	8.85	5.99	1.14	1.43	0.57	0.00	0.00
lung, right lower lobe, adult, donor1	10075-102A3	13.29	2.75	4.12	0.00	0.46	0.00	0.92	0.00
lymph node, adult, donor1	10077-102A5	11.83	3.79	2.37	0.00	0.47	0.47	0.95	0.00
lymphangiectasia cell line:DS-1	10727-110A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	1.21	0.00	0.00	0.15	0.00	0.00	1.66	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	34.83	0.85	1.70	0.85	0.85	0.85	0.00	1.70
mature adipocyte, donor1	12231-129F8	7.55	0.89	1.78	0.89	0.00	0.00	0.00	0.00
mature adipocyte, donor2	12232-129F9	2.28	1.45	2.70	0.21	0.00	0.62	0.00	0.21
mature adipocyte, donor3	12233-129G1	3.32	0.71	0.95	0.00	0.00	0.47	0.00	0.00
mature adipocyte, donor4	12234-129G2	3.16	0.79	0.53	0.00	0.00	0.53	0.00	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	4.51	1.13	1.13	2.26	1.13	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	9.75	1.10	2.94	0.37	0.18	0.00	0.00	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	6.35	1.91	1.27	0.32	0.32	0.00	0.00	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	5.97	0.00	0.85	0.00	0.00	0.00	0.00	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	7.26	1.52	0.34	0.84	0.17	0.17	0.00	0.00
medial temporal gyrus, adult, donor10252	10156-103A3	7.43	0.64	2.76	0.21	0.21	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	15.41	3.85	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	6.46	0.72	0.36	0.36	0.00	0.72	0.00	0.00
medulla oblongata - adult, donor10196	10174-103C3	25.31	3.24	1.30	0.00	0.00	0.00	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	14.40	2.63	2.32	0.31	0.46	0.15	0.00	0.00
medulla oblongata, adult, pool1	10038-101F2	15.35	1.71	2.37	0.73	0.49	0.24	0.41	0.08
medulla oblongata, newborn, donor10223	10361-105F1	18.40	1.39	1.39	1.39	0.00	0.00	0.00	0.00
medulloblastoma cell line:D283 Med	10838-111E1	29.89	15.28	16.16	3.54	3.54	4.43	0.44	1.33
medulloblastoma cell line:ONS-76	10759-110E3	18.71	7.58	2.81	0.86	1.22	0.49	0.00	0.24
melanoma cell line:COLO 679	10514-107E1	20.99	5.32	4.31	1.15	0.43	1.58	0.00	0.14
melanoma cell line:G-361	10465-106H6	20.09	3.53	2.71	0.54	1.09	0.54	0.00	0.00
meningioma cell line:HKBMM	10691-109F7	51.20	21.89	11.22	2.71	2.35	0.90	0.18	0.36
merkel cell carcinoma cell line:MKL-1	10843-111E6	74.90	7.05	14.10	5.29	0.00	0.88	1.76	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	24.89	4.67	6.74	0.52	0.26	0.26	0.52	0.26
mesenchymal precursor cell - adipose, donor1	11747-123G1	53.09	21.17	14.58	1.99	1.84	2.76	0.92	0.77
mesenchymal precursor cell - adipose, donor2	11748-123G2	30.36	22.72	9.27	2.73	2.73	3.09	0.36	0.55
mesenchymal precursor cell - adipose, donor3	11749-123G3	41.82	18.22	4.14	1.24	1.24	2.07	0.41	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	42.28	16.15	6.74	1.40	1.55	1.69	0.00	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	46.60	25.80	7.13	2.50	4.04	1.93	0.19	1.16
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	74.27	10.41	6.94	1.39	2.08	0.69	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	26.43	13.90	10.30	1.37	2.40	0.86	0.00	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	37.38	21.62	8.40	2.53	3.45	2.42	0.23	0.23
mesenchymal precursor cell - cardiac, donor3	11754-123G8	38.07	28.12	11.14	1.46	1.99	3.32	0.80	0.53
mesenchymal precursor cell - cardiac, donor4	11755-123G9	37.27	21.88	11.21	1.76	2.16	3.38	0.14	0.68
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	27.31	20.06	11.10	1.00	1.85	3.56	0.14	0.57
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	33.26	8.89	7.58	0.00	1.98	1.32	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	26.29	25.60	8.86	1.66	1.80	3.46	0.42	0.83
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	27.58	15.36	10.47	0.35	0.70	0.35	0.35	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	21.44	20.62	7.76	0.82	1.22	1.22	0.00	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	23.72	17.97	8.99	1.44	1.80	2.16	0.36	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	40.55	16.45	13.35	1.34	2.17	0.93	0.21	0.52
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	25.31	10.94	7.07	0.23	0.46	2.05	0.00	0.46
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	43.21	11.75	8.39	0.42	0.84	2.10	0.00	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	31.53	21.67	11.21	0.45	1.34	2.39	0.00	0.30
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	34.84	20.57	9.37	1.49	2.54	2.19	0.35	0.70
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	22.09	20.99	9.57	2.21	1.10	2.58	0.37	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	20.60	19.17	10.30	2.00	1.43	2.00	0.00	0.86
mesenchymal stem cell line:Hu5/E18	10568-108B1	93.89	26.52	18.95	1.68	2.11	1.26	0.84	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	51.15	20.09	12.33	2.74	1.83	7.31	0.91	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	58.32	18.16	10.49	1.28	2.05	1.53	0.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	69.37	14.92	12.83	2.09	1.31	2.09	0.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	63.77	21.87	10.78	0.92	1.23	2.77	0.00	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	55.31	19.06	9.65	0.47	2.35	1.88	0.71	0.47
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	62.95	20.31	12.52	2.03	1.02	1.02	0.00	0.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	69.16	19.26	13.36	0.39	1.18	1.57	1.18	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	53.29	11.58	11.58	1.85	1.39	1.85	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	96.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	72.39	23.94	15.00	1.44	2.88	2.02	1.15	0.58
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	59.57	18.07	9.82	0.89	1.34	2.01	0.67	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	61.77	16.34	10.58	0.96	0.72	1.92	0.48	0.72
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	35.20	16.13	10.27	0.73	3.67	0.00	1.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	58.74	18.80	13.43	2.01	1.34	3.69	0.34	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	71.64	12.28	13.92	1.23	0.82	2.05	1.23	1.23
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	61.43	16.32	11.60	1.29	0.43	0.86	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	73.83	21.88	2.73	0.00	5.47	2.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	56.81	20.66	20.66	5.16	0.00	5.16	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	72.10	18.84	12.67	1.95	1.62	2.92	0.65	0.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	66.93	18.91	20.37	2.91	1.45	2.91	1.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	72.50	25.05	13.86	1.07	1.60	2.67	0.53	1.07
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	66.24	12.27	13.08	2.45	2.45	2.45	0.00	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	59.09	18.27	10.11	0.78	1.55	3.11	1.55	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	67.16	29.38	14.69	0.00	2.10	0.00	4.20	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	69.54	14.90	11.92	0.00	0.99	4.97	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	66.74	4.77	9.53	0.00	4.77	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	53.96	12.45	10.67	2.37	0.59	3.56	0.00	1.19
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	57.27	20.71	14.62	2.44	0.00	4.87	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	108.21	0.00	27.05	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	64.61	20.90	8.87	1.90	0.63	3.17	0.00	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	59.32	18.97	10.69	1.38	0.69	1.72	0.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	53.73	12.90	12.90	2.15	4.30	8.60	0.00	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	67.86	3.99	3.99	0.00	0.00	7.98	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	55.10	13.78	17.22	6.89	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	58.68	14.26	9.78	0.81	1.22	0.41	0.41	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	57.99	15.89	15.89	0.79	0.00	0.79	0.00	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	57.77	10.02	7.07	0.59	1.18	0.59	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	64.21	10.60	9.04	0.94	0.62	0.62	0.62	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	52.13	5.35	10.69	0.00	0.00	1.34	1.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	37.85	5.91	5.91	0.00	3.55	1.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	33.38	7.70	5.14	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	37.17	15.14	6.88	1.38	0.69	2.07	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	12.37	7.92	8.41	1.48	2.47	1.48	0.49	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	16.82	6.73	5.61	1.12	1.12	3.36	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	17.17	6.36	7.00	0.64	1.91	1.91	0.00	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	7.25	4.84	7.25	2.42	0.81	1.21	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	10.90	17.44	8.72	0.00	4.36	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	10.14	1.27	3.80	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	6.07	2.43	6.07	2.43	0.61	1.82	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	13.56	4.52	4.52	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	7.41	6.59	4.94	2.47	0.00	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	38.89	5.56	3.17	1.79	1.59	2.78	0.40	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	37.32	9.41	10.38	2.92	0.65	2.92	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	40.75	9.17	5.09	1.02	2.04	1.02	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	34.82	10.83	6.19	3.09	2.32	1.55	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	28.59	5.67	8.98	0.94	0.24	0.71	0.00	0.24
mesothelioma cell line:ACC-MESO-4	10494-107B8	23.40	13.90	5.56	4.40	4.17	4.17	0.23	1.16
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	34.19	4.27	8.55	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	39.66	17.47	8.63	1.03	1.85	2.16	0.31	0.41
mesothelioma cell line:Mero-25	10850-111F4	42.44	10.44	5.67	6.58	2.72	4.77	3.40	1.36
mesothelioma cell line:Mero-41	10851-111F5	48.16	20.78	15.65	3.42	1.71	3.18	0.49	0.73
mesothelioma cell line:Mero-48a	10852-111F6	79.05	31.22	19.04	3.10	4.43	2.66	0.89	0.44
mesothelioma cell line:Mero-82	10853-111F7	31.54	12.09	6.31	5.26	2.89	4.20	0.26	1.31
mesothelioma cell line:Mero-83	10854-111F8	34.55	40.68	15.15	2.89	2.89	4.26	1.02	0.85
mesothelioma cell line:Mero-84	10855-111F9	78.87	31.85	15.42	4.04	3.79	4.55	0.51	1.52
mesothelioma cell line:Mero-95	10856-111G1	45.34	18.84	11.59	3.31	2.07	3.52	0.41	1.66
mesothelioma cell line:NCI-H2052	10847-111F1	44.39	16.73	13.09	1.33	1.16	2.32	0.50	0.33
mesothelioma cell line:NCI-H226	10846-111E9	40.90	19.19	7.06	6.88	5.07	3.26	0.54	1.09
mesothelioma cell line:NCI-H2452	10848-111F2	32.46	20.33	12.98	1.71	3.07	1.54	0.17	0.51
mesothelioma cell line:NCI-H28	10845-111E8	53.69	16.79	23.16	3.05	1.27	1.53	0.25	1.27
mesothelioma cell line:No36	10857-111G2	49.26	17.94	17.29	4.24	5.55	1.63	1.30	0.33
mesothelioma cell line:ONE58	10858-111G3	34.41	27.37	10.57	7.86	3.52	1.90	0.00	0.27
migratory langerhans cells, donor1	11901-125F2	9.21	0.19	0.77	0.19	0.00	0.96	0.19	0.19
migratory langerhans cells, donor2	11902-125F3	8.30	0.00	0.61	0.24	0.00	0.12	0.24	0.24
migratory langerhans cells, donor3	11903-125F4	14.18	0.18	0.90	0.54	0.00	0.36	0.54	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	26.44	13.06	4.57	5.55	4.57	1.31	0.00	0.65
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	28.61	13.99	10.38	4.03	2.33	1.70	1.91	0.42
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	45.84	13.13	13.59	0.69	0.46	0.23	0.00	0.69
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	92.58	1.66	3.14	0.74	0.37	0.55	0.18	0.00
myeloma cell line:PCM6	10474-106I6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	29.93	9.64	7.61	1.01	2.03	0.51	0.00	1.52
myxofibrosarcoma cell line:NMFH-1	10684-109E9	62.96	5.30	7.06	0.20	0.78	0.00	0.00	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	19.39	3.68	3.68	0.78	0.22	0.22	0.00	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	22.50	2.87	3.97	0.29	0.07	0.74	0.00	0.15
nasal epithelial cells, donor2	12227-129F4	20.42	4.42	1.66	0.00	0.55	1.10	0.00	0.55
neuroblastoma cell line:CHP-134	10508-107D4	31.06	2.53	1.61	0.46	0.46	0.92	0.69	0.23
neuroblastoma cell line:NB-1	10539-107G8	60.05	16.65	5.61	4.30	1.12	7.30	1.68	1.50
neuroblastoma cell line:NBsusSR	10607-108F4	22.14	20.67	10.54	1.48	2.11	1.48	0.21	0.63
neuroblastoma cell line:NH-12	10555-107I6	22.36	3.73	4.10	1.49	0.56	0.56	0.00	1.30
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	16.13	24.67	12.57	0.71	0.24	0.47	0.24	0.71
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	19.01	27.72	14.89	0.63	1.27	2.69	3.01	0.63
neuroectodermal tumor cell line:TASK1	10774-110F9	24.15	13.48	11.47	1.21	1.61	1.21	0.40	0.40
neuroepithelioma cell line:SK-N-MC	10728-110A8	17.17	8.26	11.44	1.27	0.00	0.00	1.27	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	25.82	21.29	9.85	1.06	1.33	2.40	0.53	0.53
neutrophil PMN, donor1	12133-128D9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	9.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	0.51	0.00	0.00	0.00	0.00	0.00	1.69	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	20.81	0.00	1.60	0.00	0.00	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	69.25	29.50	9.30	9.94	11.86	4.81	1.92	0.96
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	53.34	27.33	13.66	2.63	3.15	3.42	0.79	0.53
nucleus accumbens, adult, pool1	10037-101F1	7.59	1.97	1.78	1.59	0.28	0.19	0.09	0.09
occipital cortex - adult, donor10196	10172-103C1	2.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	9.39	2.15	3.76	0.54	0.00	0.27	0.00	0.27
occipital cortex, newborn, donor10223	10355-105E4	6.91	0.36	0.36	0.00	0.00	0.36	0.00	0.00
occipital lobe, adult, donor1	10076-102A4	7.08	1.31	2.10	0.00	0.26	0.26	0.26	0.26
occipital lobe, fetal, donor1	10073-102A1	3.86	0.86	0.00	0.43	0.00	0.00	0.43	0.43
occipital pole, adult, pool1	10036-101E9	6.94	1.50	1.50	0.95	0.47	0.39	0.00	0.00
olfactory region, adult	10195-103E6	7.07	2.67	1.91	1.15	0.00	0.19	0.19	0.00
optic nerve, donor1	10277-104E7	18.01	0.00	6.00	0.00	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	29.96	9.45	6.15	2.51	0.80	0.23	0.11	0.11
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	21.02	19.23	9.62	4.53	2.75	1.10	0.82	0.27
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	30.48	8.30	3.39	2.88	1.19	1.35	0.00	0.68
oral squamous cell carcinoma cell line:SAS	10544-107H4	53.37	13.98	4.04	9.36	5.08	4.85	0.00	1.27
osteoclastoma cell line:Hs 706.T	10704-109H2	35.86	18.81	17.34	0.29	1.76	0.00	0.29	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	12.15	3.74	1.87	0.00	0.00	1.87	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	22.27	7.00	2.12	6.79	3.39	3.18	0.21	1.27
ovary, adult, pool1	10020-101D2	68.75	10.22	6.03	1.14	1.05	2.27	0.61	0.35
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	23.65	8.07	4.77	0.55	0.92	0.37	0.00	0.00
pancreas, adult, donor1	10049-101G4	1.88	1.88	0.94	0.00	0.00	0.00	0.94	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	2.80	9.22	4.19	4.19	1.12	2.80	0.28	0.56
papillary adenocarcinoma cell line:8505C	10437-106E5	36.11	17.38	4.94	4.94	4.09	2.90	0.34	0.51
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	9.44	2.48	2.81	0.00	0.17	0.00	0.00	0.00
paracentral gyrus, adult, pool1	10035-101E8	6.22	1.46	1.46	0.82	0.27	0.09	0.00	0.09
parietal cortex, adult, donor10258	10373-105G4	4.40	0.73	0.73	0.00	0.00	0.00	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	3.76	1.88	1.88	0.00	0.00	0.94	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	8.55	0.86	1.43	0.29	0.00	0.00	0.00	0.29
parietal lobe, adult, pool1	10034-101E7	7.40	1.41	1.06	0.44	0.35	0.00	0.00	0.00
parietal lobe, fetal, donor1	10072-101I9	2.91	0.00	1.94	0.00	0.00	0.97	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	8.22	0.00	0.75	0.37	0.00	1.12	0.00	0.00
parotid gland, adult	10199-103F1	7.40	0.62	3.08	0.00	0.00	0.62	0.00	0.62
penis, adult	10200-103F2	34.91	5.37	2.15	0.54	0.00	1.07	0.00	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	28.63	4.65	5.39	0.00	0.00	0.00	0.19	0.19
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	17.77	12.68	5.97	2.91	4.66	2.33	1.02	0.58
pineal gland - adult, donor10196	10179-103C8	8.39	1.29	1.94	0.00	0.00	0.00	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	4.15	0.59	1.18	0.00	0.00	0.00	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	5.02	4.39	0.00	0.00	0.00	0.00	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	14.17	0.00	1.01	0.00	0.00	0.00	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	15.64	3.65	3.65	0.00	0.00	0.00	0.00	0.00
pituitary gland, adult, donor10258	10378-105G9	11.07	0.85	2.55	0.00	0.00	0.00	0.00	0.00
placenta, adult, pool1	10021-101D3	12.04	2.04	3.44	0.32	0.22	0.22	0.00	0.00
plasma cell leukemia cell line:ARH-77	10840-111E3	9.14	0.40	1.06	0.53	0.13	0.66	0.26	0.66
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	27.55	6.54	6.69	0.78	1.40	0.78	0.00	0.16
pons, adult, pool1	10033-101E6	5.34	1.03	0.86	0.17	0.00	0.09	0.00	0.00
postcentral gyrus, adult, pool1	10032-101E5	5.67	2.01	2.35	0.61	0.26	0.44	0.26	0.00
promyelocytes/myelocytes PMC, donor1	12132-128D8	4.18	2.09	2.09	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	44.06	5.51	5.51	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	46.94	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	47.63	28.99	16.90	2.91	3.20	1.46	0.73	0.29
prostate cancer cell line:PC-3	10439-106E7	21.24	12.52	8.17	0.36	1.45	2.18	0.00	0.73
prostate, adult, pool1	10022-101D4	60.04	4.08	7.07	0.73	0.18	0.73	0.36	0.18
putamen, adult, donor10196	10176-103C5	10.15	3.30	2.36	1.65	0.00	0.24	0.00	0.24
putamen, adult, donor10252	10152-102I8	19.61	0.00	1.96	0.00	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	14.21	7.65	1.09	3.28	1.09	2.19	4.37	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	3.38	0.72	1.45	0.48	0.24	0.48	0.00	0.00
putamen, newborn, donor10223	10365-105F5	1.50	0.00	0.75	0.00	0.00	0.75	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
rectum, fetal, donor1	10067-101I4	33.38	22.26	2.78	1.39	2.78	8.35	2.78	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	40.49	7.63	11.45	0.64	1.91	0.42	0.00	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	26.10	1.24	4.56	0.00	0.00	0.00	0.00	0.00
retina, adult, pool1	10030-101E3	39.06	6.16	11.23	0.80	0.20	0.99	0.99	0.50
retinoblastoma cell line:Y79	10475-106I7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	10.94	24.47	7.50	4.43	2.21	1.60	3.93	0.25
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	54.27	21.37	7.03	2.25	3.09	2.81	2.53	0.84
sacrococcigeal teratoma cell line:HTST	10695-109G2	38.65	22.74	5.30	1.52	1.52	0.76	0.00	0.76
salivary acinar cells, donor1	11771-123I7	16.51	12.95	7.77	0.49	0.49	0.16	0.32	0.32
salivary acinar cells, donor2	11772-123I8	28.64	7.57	8.95	0.96	0.69	0.41	0.00	0.00
salivary acinar cells, donor3	11773-123I9	24.50	7.28	5.96	0.00	0.00	0.00	0.00	0.00
salivary gland, adult, pool1	10093-102C3	6.86	1.14	0.57	0.00	0.00	0.00	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	75.63	11.72	8.85	2.19	2.28	1.01	0.59	0.08
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	69.94	14.22	8.58	3.53	1.53	0.82	0.47	0.59
seminal vesicle, adult	10201-103F3	30.16	8.47	10.58	0.53	0.00	1.59	0.53	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	18.71	12.15	5.59	5.59	3.40	2.43	0.49	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	16.61	3.02	0.25	0.00	0.00	0.25	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	15.05	2.01	0.00	0.00	0.00	0.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	33.45	10.07	4.43	4.70	2.69	0.54	0.54	0.40
signet ring carcinoma cell line:Kato III	10436-106E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	30.19	5.29	4.77	0.65	0.52	0.00	0.39	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	7.09	0.00	0.00	0.00	0.00	0.00	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	11.03	1.92	2.28	0.24	0.12	0.12	0.24	0.12
skeletal muscle, fetal, donor1	10066-101I3	13.07	7.04	5.03	1.01	0.00	1.01	0.00	0.00
skin, adult, donor1	10074-102A2	13.57	13.57	0.00	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	18.94	10.73	6.94	1.26	0.63	2.52	0.63	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	17.01	5.00	4.67	1.00	0.67	0.33	0.00	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	31.52	7.56	7.25	2.84	2.52	3.15	0.32	0.95
small cell lung carcinoma cell line:DMS 144	10841-111E4	7.52	6.17	12.91	1.35	0.96	1.54	0.00	1.16
small cell lung carcinoma cell line:LK-2	10541-107H1	15.33	11.70	7.75	2.97	0.82	3.46	0.00	1.32
small cell lung carcinoma cell line:NCI-H82	10842-111E5	22.68	2.25	4.02	0.48	0.64	0.16	0.16	0.48
small cell lung carcinoma cell line:WA-hT	10562-108A4	29.20	6.97	3.92	2.18	1.74	1.53	1.09	1.31
small intestine, adult, pool1	10024-101D6	14.09	2.03	1.91	0.24	0.00	0.48	0.12	0.00
small intestine, fetal, donor1	10064-101I1	27.76	5.65	4.67	0.74	0.98	1.97	3.69	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	1.03	0.51	0.51	0.00	0.00	0.00	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	49.88	3.36	10.08	1.03	0.26	1.03	0.00	0.00
somatostatinoma cell line:QGP-1	10781-110G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	15.83	0.46	2.06	0.23	0.23	0.23	0.00	0.00
spinal cord, adult, donor10252	10159-103A6	14.19	0.79	1.18	0.79	0.00	0.00	0.00	0.00
spinal cord, adult, donor10258	10369-105F9	16.60	0.69	1.38	2.08	0.00	0.69	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	15.25	5.49	4.88	1.22	1.83	0.61	0.00	1.22
spinal cord, newborn, donor10223	10359-105E8	16.07	1.38	0.92	0.46	0.46	0.46	0.00	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	30.02	20.61	7.02	1.05	1.79	2.54	0.00	0.15
spleen, adult, pool1	10025-101D7	12.11	1.76	3.30	0.11	0.00	0.22	0.11	0.33
spleen, fetal, pool1	10044-101F8	11.12	3.73	2.62	1.03	0.24	0.40	0.48	0.16
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	26.58	7.41	7.60	2.47	0.95	0.57	0.00	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	12.23	9.44	10.83	0.35	1.75	0.00	1.05	0.70
squamous cell carcinoma cell line:T3M-5	10616-108G4	23.06	11.34	5.47	1.56	0.00	1.56	0.00	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	37.71	6.19	3.38	3.71	0.79	0.90	0.00	0.56
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	34.74	2.54	3.81	0.85	0.85	0.00	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	11.00	8.46	2.96	1.27	1.27	1.27	0.42	0.00
stomach, fetal, donor1	10062-101H8	18.16	9.61	2.14	0.00	0.00	2.14	0.00	0.00
submaxillary gland, adult	10202-103F4	10.25	1.14	2.28	0.57	0.57	0.57	0.00	0.57
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	9.76	0.83	1.45	0.21	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10258	10371-105G2	11.90	1.55	4.14	0.52	0.52	0.00	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	14.84	0.71	0.00	1.41	0.00	0.00	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	22.24	25.22	13.99	2.29	0.92	2.98	0.46	2.06
temporal lobe, adult, pool1	10031-101E4	8.22	2.80	2.71	1.27	0.68	0.17	0.17	0.25
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	1.42	3.56	1.42	0.71	0.00	0.71	0.00	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	6.59	3.96	2.20	0.88	0.00	0.00	0.00	0.88
tenocyte, donor1	11763-123H8	74.71	26.18	11.87	3.84	3.84	2.09	0.00	0.35
tenocyte, donor2	11765-123I1	96.90	27.85	17.55	2.29	2.67	1.53	0.00	0.00
tenocyte, donor3	11768-123I4	58.94	24.09	16.68	1.48	3.34	1.11	0.74	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	20.23	10.54	5.95	1.53	1.87	2.38	6.46	1.36
teratocarcinoma cell line:NCR-G1	10798-110I6	22.81	16.65	3.39	4.32	3.55	4.47	0.77	0.77
teratocarcinoma cell line:PA-1	10807-111A6	37.66	13.48	2.63	4.34	3.10	2.79	1.39	0.31
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	21.71	18.66	4.95	2.41	2.41	2.03	4.57	0.76
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	24.58	10.59	3.40	5.67	1.13	3.78	6.43	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	29.66	6.11	1.64	2.18	1.09	2.84	0.98	0.55
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	19.87	5.21	2.93	1.30	0.98	1.63	22.80	0.65
testis, adult, pool1	10026-101D8	30.92	5.15	4.40	0.32	0.32	1.07	0.21	0.21
testis, adult, pool2	10096-102C6	10.83	3.16	3.16	0.45	0.00	0.45	0.45	0.00
thalamus - adult, donor10196	10168-103B6	7.73	0.00	2.21	0.00	0.00	0.00	0.00	0.00
thalamus, adult, donor10252	10154-103A1	10.94	1.56	1.41	0.00	0.00	0.16	0.00	0.00
thalamus, adult, donor10258, tech_rep1	10370-105G1	26.17	0.00	0.00	1.54	0.00	0.00	1.54	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	10.54	1.48	1.65	0.49	0.00	0.00	0.00	0.00
thalamus, newborn, donor10223	10366-105F6	7.48	0.58	0.00	0.58	0.00	0.58	0.58	0.00
throat, adult	10209-103G2	16.98	1.75	5.74	0.25	0.50	0.25	0.25	0.00
throat, fetal, donor1	10061-101H7	16.76	7.31	8.23	0.61	0.61	0.91	0.30	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	1.39	13.12	13.71	0.99	0.60	1.79	0.00	2.19
thymus, adult, pool1	10027-101D9	6.76	1.39	1.19	0.30	0.40	0.60	0.10	0.00
thymus, fetal, pool1	10043-101F7	6.55	1.77	2.18	0.31	0.10	0.10	0.52	0.10
thyroid carcinoma cell line:KHM-5M	10776-110G2	58.77	7.18	8.91	1.33	1.46	1.20	0.13	0.27
thyroid carcinoma cell line:TCO-1	10783-110G9	20.53	15.65	5.17	2.79	4.05	4.75	0.14	1.26
thyroid, adult, pool1	10028-101E1	44.23	8.40	13.44	0.47	0.28	0.93	0.37	0.19
thyroid, fetal, donor1	10060-101H6	20.83	8.70	9.76	0.26	0.53	1.05	0.26	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	40.04	6.16	3.08	0.00	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	21.40	3.49	2.09	0.70	0.23	0.23	0.00	0.00
tongue, fetal, donor1	10059-101H5	15.37	9.46	6.31	0.39	0.79	1.97	0.00	0.39
tonsil, adult, pool1	10047-101G2	17.63	2.10	2.40	0.60	0.10	0.90	0.50	0.10
trachea, adult, pool1	10029-101E2	23.64	4.17	4.74	0.33	0.16	0.25	0.49	0.25
trachea, fetal, donor1	10058-101H4	30.78	7.69	7.69	1.15	0.00	1.15	0.00	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	46.76	24.09	8.50	2.13	3.54	4.25	0.35	0.71
transitional-cell carcinoma cell line:5637	10418-106C4	45.39	15.91	6.08	5.07	3.34	2.23	0.81	0.51
transitional-cell carcinoma cell line:JMSU1	10492-107B6	58.91	14.26	6.74	5.01	4.07	2.04	1.41	1.10
tridermal teratoma cell line:HGRT	10694-109G1	38.05	15.22	7.61	0.00	0.00	1.90	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	32.59	6.43	8.89	0.51	0.51	0.42	0.08	0.25
umbilical cord, fetal, donor1	10057-101H3	35.47	4.17	14.61	0.00	2.09	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	66.37	6.83	8.70	1.19	1.37	0.68	0.17	0.00
uterus, fetal, donor1	10055-101H1	23.04	17.41	9.21	3.07	2.05	2.05	3.58	0.51
vagina, adult	10204-103F6	24.56	3.23	4.52	0.00	0.00	0.65	0.00	0.00
vein, adult	10191-103E2	15.12	2.85	3.73	0.44	0.00	0.22	0.44	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00

Property "Nearest transcripts" (as page type) with input value "LF326828:20 MA562405:20 LF213771:-29 MA449348:-29 ENST00000636513.1:35 ENST00000636154.2:35 ENST00000483554.1:36 ENST00000636772.1:-85 ENST00000395245.9:-103 NM_001256281.3:-103 NM_031934.6:-103 NM_001144942.2:-103 AK074689:-103 BC091510:317 ENST00000422279.6:350 LF326829:387 MA562406:387 AF327350:-390 ENST00000436730.7:-396 ENST00000625712.2:-401 ENST00000450529.5:-401 AK297850:-401 ENST00000583538.5:-402 ENST00000419712.7:-402 ENST00000580843.6:-402 ENST00000482688.5:-402 ENST00000582934.1:-402 NM_001256277.2:-402 NM_001256276.2:-402 AK027312:-402 AJ277106:-404 ENST00000415040.6:-418 BC066904:-418 AK304633:-418 ENST00000353676.9:-457 AF322067:477 CU677737:477 KJ894907:477 KJ899729:477 BT006702:477 DQ890590:477 DQ893756:477 CU688184:477" contains invalid characters or is incomplete and therefore can cause unexpected results during a query or annotation process.